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S U M M A R Y  
 
The alarming rise of antimicrobial resistance in pathogenic strains has fuelled 
tremendous research efforts towards the discovery of novel bioactive molecules from 
untried ecological niches. In this regard, the world’s oceans have revealed to be a 
remarkable resource of new bacterial taxa with promising biosynthetic potential. Study 
of the secondary metabolism of the marine actinobacterium Salinispora, for instance, 
has shown the genus to be an exceptional trove of unique and bioactive natural products, 
rivalling the significance of its terrestrial counterpart. 
The isolation of new secondary metabolites from members of the genus Salinispora and 
other microorganism is, however, currently limited because most of the biosynthetic 
gene clusters (BGCs) encoded in their genomes are not expressed under standard 
laboratory conditions. This is well exemplified in Salinispora, as a staggering 80% of its 
BGCs are still orphan (i.e. not linked to their products). This observation warrants the 
development of new approaches to unlock the biosynthetic potential of the genus.  
This thesis is devoted to investigating novel ways to activate, interrogate, and 
manipulate the biosynthetic potential of Salinispora tropica CNB-440. First, we 
demonstrate how co-cultivation of S. tropica with phytoplankton could be used to elicit 
the production of novel cryptic compounds in the actinobacterium. Our data also reveal 
that S. tropica exhibits antimicrobial activity against a range of eukaryotic and 
prokaryotic marine phototrophs via an uncharacterized mechanism. 
Second, we report the first proteome dataset available in the genus Salinispora, that we 
explored in order to identify candidate secondary pathways responsible for the 
biosynthesis of the detected cryptic molecules and/or the antimicrobial activity observed 
in co-culture. Using high-throughput proteomics, we provide evidence that the orphan 
nrps1 BGC is active and upregulated upon exposure to phytoplankton. We also suggest 
a potential mechanistic understanding of the antimicrobial effect seen in co-culture. 
Finally, we implemented for the first time the CRISPR/Cas9 system in a member of the 
genus Salinispora, as a promising tool to link specific BGCs to the detected molecules 
and/or observed bioactivity described in our study. As a proof of concept, we successfully 
engineered S. tropica by deleting an entire BGC and a PPTase from its genome. 
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C H A P T E R  1  |  I N T R O D U C T I O N  
 
1.  A BRIEF HISTORY OF ANTIBIOTICS 
Human health has been shaped by the use of drugs for millennia, starting with traditional 
medicines that have harnessed plant-derived molecules to treat various human illnesses. 
The Artemisia plant had been, for instance, used by Chinese herbalists as a remedy 
thousands of years ago, long before artemisinin was extracted from the plant and used 
as an anti-malarial drug (Cui & Su, 2009). More recently in history, the discovery of the 
microbe-derived antibiotic penicillin by Alexander Fleming in 1929 (Fleming, 1929) has 
been one of the most significant breakthroughs in modern medicine. Its successful use 
to treat bacterial infections has saved countless lives and has marked the dawn of the 
‘Golden age’ of antibiotic discovery. This era, spanning from 1940 to 1962, witnessed the 
discovery of most of the microbial natural scaffolds from which pioneering drugs used 
today have been based upon. Antibiotics introduced during this period were mostly 
sourced from the specialized metabolism of bacteria and fungi and are grouped into 
different chemical classes, including b-lactams, aminoglycosides, glycopeptide and 
macrolides (Aminov, 2010; Brown & Wright, 2016). The identification of novel scaffolds 
following the golden era has, however, been virtually null with the latest class being 
reported in 1987; even if their representative antibiotics were ultimately marketed in 
the early 2000s (Fig. 1; Coates, Halls, & Hu, 2011; Silver, 2011).  
The decline of the discovery rate of novel antimicrobials has become especially critical 
since it has been paralleled by a growing public health crisis caused by antimicrobial 
resistance (AMR) (Carlet et al., 2011). While AMR is a natural phenomenon whereby 
bacteria evolve mechanisms (i.e. by random point mutations or horizontal gene transfer) 
to survive antimicrobials exposure, the inappropriate use of antibiotics has set an 
unprecedented selective pressure upon pathogens that fuelled the rapid advent of 
multidrug resistant bacteria (MRB), rendering entire classes of antibiotics useless. For 
instance, a group of pathogenic bugs collectively named ESKAPE (Enterococcus faecium, 
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanni, Pseudomonas 
aeruginosa and Enterobacter spp.), have developed resistance mechanisms to the most 
commonly used antibiotics and are responsible for an increasing number of nosocomial 
infections (De Oliveira et al., 2020; Rice, 2008). Overall, it has been estimated that MRB 
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caused about 25,000 deaths across Europe in 2007 and 35,000 more in the U.S. (Colomb-
Cotinat et al., 2016), and these numbers are set to worsen in the future. A review 
commissioned by the United Kingdom government indeed estimated that AMR could 
cause about 10 million deaths annually by 2050 (de Kraker et al., 2016; O’Neill, 2014), 
highlighting the urgency with which novel bioactive compounds are needed.  
 
2. EXPLOITING NATURAL PRODUCTS FOR DRUG DISCOVERY 
Natural products have undisputedly played a pivotal role in the discovery and 
development of medicines like antibiotics (Dias et al., 2012). These organic compounds 
derive from the primary or rather secondary metabolism of living entities, including 
plants, animals and microorganisms. Primary metabolites are directly involved in the 
growth, development or reproduction of an organism (e.g. polysaccharides, nucleic and 
fatty acids). In contrast, secondary metabolites are low molecular mass compounds (i.e. 
molecular weight < 3,000) often characteristic of a narrow range of species, with cryptic 
physiological functions deemed non-essential for the viability of the producing organism. 
Instead, they play a role in the adaptation to its environment and may be involved in 
defence or communication mechanisms (Dias et al., 2012). While natural products can 
be sorted into four main chemical classes (i.e. polyketides, nonribosomal peptides, 
terpenoids and steroids, alkaloids) (McMurry, 2009), their remarkable structural 
 
Figure 1 | Timeline of the discovery of the antibiotic classes in clinical use. The ‘discovery void’ 
represents the period since when the last antibiotic class successfully used as a treatment has 
been discovered or patented. Figure is adapted from Silver, 2011. 
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diversity makes them a valuable reservoir of bioactive molecules with potential clinical 
relevance. The number of natural products discovered to this day exceeds 1 million, of 
which approximately 20-25% show biological activity ranging from anti-cancer, 
immunosuppressant or antibiotics (Demain & Sanchez, 2009). These bioactive 
compounds have continued to enter clinical trials to provide new drugs, as a 
comprehensive analysis of new medicines approved by the US Food and Drug 
Administration (FDA) between 1981 and 2014 showed that 33% of those small molecule-
based medicines were natural products or derivatives of natural products (Fig. 2; 
Newman & Cragg, 2016). 
Despite the contribution of natural product research for the development of novel drugs, 
low-throughput fermentation processes and the rediscovery of already known 
secondary metabolites led to a noticeable disinterest of most biopharmaceutical 
companies for this field in the late 20th century (Brown & Wright, 2016; Christopher 
Walsh, 2017). This was further aggravated by the advances at the time of alternative 
discovery platforms, driven by high-throughput screening and combinatorial synthesis, 
which were thought to be a more productive approach to drug discovery. However, low 
returns from the aforementioned alternative strategies, coupled with the growing 
demand for new drugs caused by the AMR crisis, eventually resulted in a renewed 
enthusiasm to exploit the diversity of natural products for drug discovery (Pham et al., 
 
Figure 2 | Sources of all small-molecule drugs approved by the U.S. FDA. Approved from 1981 
to 2014, with n = 1,211. Mimic of Natural Products refers to synthetic compounds showing 
competitive inhibition of the natural product substrate. Figure is adapted from Newman & 
Cragg, 2016. 
group
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2019; Shen, 2015). In particular, the significance of small molecules derived from 
microbial sources was supported by improvements in sequencing technologies, allowing 
genome sequencing of various microbes such as the soil actinomycete Streptomyces 
coelicolor, which revealed an untapped wealth of secondary metabolites awaiting to be 
uncovered (Baltz, 2019; Bentley et al., 2002). 
 
3. ACTINOBACTERIA - A WEALTH OF BIOACTIVE COMPOUNDS 
Actinobacteria are an extremely diverse phylum of Gram-positive bacteria with a high G-
C content, including rod-shaped and filamentous cells. Although they are ubiquitous of 
soil and water ecosystems, soil actinomycetes have been historically the most prolific 
source of clinically-relevant natural products. In particular, species from the genus 
Streptomyces, which are aerobic soil-dwelling filamentous bacteria reproducing by 
sporulation, account for most of the bioactive compounds discovered to date.  
 
 
During the mid-1900s, more than 60% of bioactive microbial metabolites were sourced 
from actinobacteria and almost exclusively from Streptomyces spp. (Fig. 3; Bérdy, 2012). 
Although this proportion decreased in recent years in favour of fungi-derived 
metabolites, actinobacteria still account for a significant portion of the pool of reported 
bioactive molecules, making up to 30% of all the molecules discovered during the 2001 
to 2010 period (Fig. 3). Overall, it has been estimated that from the 33,500 bioactive 
 
Figure 3 | Distribution of the reported bioactive microbial natural products according to their 
origin (1940-2010). Figure is adapted from Bérdy, 2012. 































metabolites that have been reported from microbes so far, 45% are produced by 
actinomycetes, of which 76% were isolated from Streptomyces spp. (Bérdy, 2012). More 
specifically, the Streptomyces genus alone yielded over two-third of all antibiotics used 
today, as the main antimicrobial chemical scaffolds derive from Streptomyces-isolated 
compounds (Bérdy, 2005; Genilloud, 2017; Takahashi & Nakashima, 2018). For instance, 
the b-lactam cephamycin was isolated from Streptomyces clavuligerus (Ward & 
Hodgson, 1993), the aminoglycoside neomycin from Streptomyces fradiae (Dulmage, 
1953), the macrolide erythromycin from Streptomyces erythreus (Weber et al., 1985), 
the glycopeptide vancomycin from Streptomyces orientalis and tetracycline from 
Streptomyces aureofaciens (Darken et al., 1960) (Fig. 4). 
The identification of novel secondary metabolites from this extensively studied soil-
dwelling genus has, however, slowed down over the last few decades because of the 
recurring rediscovery of already known compounds (Coates et al., 2011). This resulted in 
a growing interest to explore the bacterial diversity of overlooked ecological niches and 
taxonomic groups, with the rationale that ecologically distinct microorganisms produce 
 
Figure 4 | Structures of representative antibiotics discovered in Streptomyces. 

















































































equally distinct natural products (Bull & Goodfellow, 2019; Molinski et al., 2009; Z. E. 
Wilson & Brimble, 2009). The world’s oceans, covering 70% of the Earth’s surface, have 
typically been poorly studied ecosystems, in part because of limited technologies and 
equipment allowing the exploration of this vast habitat. Our knowledge of the marine 
environment has nonetheless improved dramatically over the years and we now know 
that complex and diverse microbial communities inhabit the oceans. One millilitre of 
seawater commonly hosts about one million microorganisms, while their abundance in 
ocean-bottom sediments reaches up to one billion cells per millilitre (Whitman et al., 
1998). From the study of these marine communities emerged numerous interesting 
novel compounds and bacterial species for drug discovery, including the promising 
actinobacterial genus Salinispora (Baltz, 2008; Fenical & Jensen, 2006; Manivasagan, 
Kang, et al., 2014; Manivasagan, Venkatesan, et al., 2014). 
 
4. THE MARINE ACTINOBACTERIUM SALINISPORA  
Soil actinobacteria are known to produce resilient spores that withstand harsh 
conditions and remain viable although dormant for years (Cross, 1981). It has therefore 
been assumed that actinomycetes recovered from marine environments over the years 
were simply the result of spores washed up from land into the sea. This paradigm 
changed, however, upon the description in 2002 of a persistent and widely distributed 
actinomycete taxon exclusively reported from the ocean, named Salinispora (Mincer et 
al., 2002). Bacteria from this newly discovered genus, closely related to 
Micromonospora, were the first seawater-obligate marine actinomycetes to be 
 
Figure 5 | Growth and morphology of Salinispora. (A) SEM of S. arenicola M413 mycelia with 
spores forming at the tip of the mycelium, indicated by the red arrow. Picture is extracted from 
Hewavitharana, Webb, Shaw & Fuerst, 2013. (B) Photograph of a 7-day old liquid culture of S. 
tropica CNB-440 in marine broth. (C) Photograph of a 22-day old culture of S. tropica CNB-440 
on A1-agar plate. 
B CA
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described. It was later shown that they require sodium salts and that a low-ionic-strength 
environment leads to cell lysis (Tsueng & Lam, 2008). Further studies identified the loss 
of the mscL gene, which encodes a transmembrane protein involved in alleviating 
osmotic downshock, to be responsible for Salinispora’s salt requirement, thereby 
providing the first evidence that certain actinobacteria specifically adapted to marine 
ecosystems (Bucarey et al., 2012; Penn & Jensen, 2012).  
 
Salinispora are aerobic, Gram-positive heterotrophs that form a branched mycelium with 
a lack of aerial hyphae, they grow as dense aggregates in liquid and display a 
pigmentation ranging from orange to black, due to sporulation (Fig. 5) (Ng et al., 2013). 
Phylogenetic analyses of nearly complete small subunit rRNA and gyrB sequences of the 
first Salinispora isolates revealed that they formed a clade of closely related strains, with 
a 16S rRNA gene sequence identity greater than 99% (Jensen & Mafnas, 2006). While the 
genus is officially comprised of three formally described species, Salinispora tropica, 
Salinispora arenicola and Salinispora pacifica (Ahmed et al., 2013; Maldonado et al., 
2005), recent phylogenomic analyses based on average nucleotide identity of 119 strains 
suggested more species-level diversity, with the existence of 10 different candidate 
 
Figure 6 | Locations from which the genus Salinispora has been reported. Figure is extracted 
from Jensen, Moore & Fenical, 2015.   
 19 
species (Millan-Aguinaga et al., 2017). To date, S. tropica is the species with the most 
limited geographic distribution and has been reported only from the Caribbean 
(Bahamas and Yucatán), while S. pacifica and S. arenicola are broadly distributed 
throughout tropical and subtropical oceans (Fig. 6). Originally recovered from marine 
sediments of shallow waters (1-30 meters depth) (Mincer et al., 2002), Salinispora has 
since then been found in far greater depths (1-1,100 meters), and isolated from the 
microbiota of ascidian, seaweeds, marine sponges and corals (Asolkar et al., 2010; Jensen 
et al., 2005; Ocampo-Alvarez et al., 2020). The cosmopolitan distribution of Salinispora 
in the marine ecosystem raised questions about whether this diversity could be reflected 
in the genus secondary metabolic potential, similarly to what has been observed for soil 
actinobacteria (van der Meij et al., 2017). 
Genome sequencing of the type strain S. tropica CNB-440T in 2007 brought a first answer 
to these questions by providing a valuable insight into the biosynthetic capacity of the 
genus (Udwary et al., 2007). Analysis of its genome revealed a strikingly rich predicted 
secondary metabolome, with the detection of many natural product gene clusters 
accounting for 10% of its entire genome. Interestingly, a significant portion of these 
identified genomic clusters were not only found to feature polyketide synthase (PKS) and 
nonribosomal peptide synthetases (NRPS) systems (responsible for the biosynthesis of 
two of the most important classes of bioactive natural products) but they also appeared 
to be completely new biosynthetic loci (Udwary et al., 2007). Altogether, these 
observations supported the idea that novel microbial taxa from untried ecological niches 
could represent a wealth of unique molecules for drug discovery, by revealing the genus 
Salinispora as a remarkable potential source of new secondary metabolites rivalling its 
terrestrial counterpart. 
 
5.  NATURAL PRODUCTS ISOLATED FROM SALINISPORA  
Since its discovery, the genus Salinispora has proven to be a significant source of novel 
bioactive molecules with the isolation of numerous secondary metabolites, of which a 
majority were unique to the genus and showed a range of biological activities relevant 
for pharmaceutical applications (Table 1). For instance, the siderophore deferoxamine 
(Roberts et al., 2012), the immunosuppressant lymphostin (Miyanaga et al., 2011) and  
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the terpenoid sioxanthin (Richter et al., 2015) are produced by all three Salinispora 
species (Table 1). 
Although the two formers were previously reported from other microbes, sioxanthin was 
a new and unusual glycosylated carotenoid, associated with Salinispora’s orange 
pigmentation (Fig. 7). Interestingly, in contrast with the aforementioned compounds, it 
was shown that most of the metabolites reported from the genus are species-specific 
Table 1 | Natural products reported from the genus Salinispora. 
 
Bold = novel compound; trop = S. tropica; paci = S. pacifica; aren = S. arenicola; + = Compound 




Biosynthetic class Activity References
trop paci aren
Arenamide + NRPS NFkB inhibitor Asolkar et al., 2009
Arenicolide + PKS ND Williams et al., 2007
Arenimycin + PKS Antimicrobial/Cytotoxic Asolkar et al., 2010
BE-43547 + PKS-NRPS Hypoxia-selective toxicity Villadsen et al., 2016
Cyanosporaside + PKS Cytotoxic Oh et al., 2006
Cyclomarazine + NRPS Antimicrobial Schultz et al., 2008
Cyclomarin + NRPS Anti-inflammatory Schultz et al., 2010
Deferoxamine + + + Hydroxamate Siderophore Roberts et al., 2012
Enterocin + PKS Antimicrobial Bonet et al., 2015
3-hydroxy-N-methyl-2-oxindole + ND ND da Silva et al., 2019
4-hydroxy-pyran-2-one + ND ND da Silva et al., 2019
Ikarugamycin + PKS-NRPS Antimicrobial Greunke et al., 2017
Isopimara-8,15-dien-19-ol + Terpene ND Xu et al., 2014
Lomaiviticin + + PKS Cytotoxic He et al., 2001
Lymphostin + + + PKS-NRPS Immunosuppressant Miyanaga et al., 2011
6-methoxy-N-methylisatin + ND Antimicrobial da Silva et al., 2019
Mevinolin + PKS Cholesterol-lowering agent Bose et al., 2014
Pacificanone + PKS ND Oh et al., 2008
Retimycin + NRPS Cytotoxic Duncan et al., 2015
Rifamycin + PKS Antimicrobial Kim et al., 2006
Rosamicin + PKS Antimicrobial Awakawa et al., 2015
Salinaphthoquinones + ND Antimicrobial da Silva et al., 2019
Salinichelin + + Hydroxamate-NRPS Siderophore Bruns et al., 2018
Saliniketal + PKS Ornithine decarboxylase inhibitor Williams et al., 2007
Salinilactam + PKS ND Udwary et al., 2007
Salinilactone + ND Antimicrobial Schlawis et al., 2018
Salinipostin + + Butyrolactone Cytotoxic/antimalarial Schulze et al., 2015
Salinipyrone + PKS ND Oh et al., 2008
Saliniquinone + PKS Cytotoxic Murphy et al., 2010
Salinisporamide + + PKS-NRPS Cytotoxic Feling et al., 2003
Sioxanthin + + + Terpene ND Richter et al., 2015
Sporolide + PKS HIV reverse transcriptase Buchanan et al., 2005
Staurosporine + Alkaloid Protein kinase inhibitor Jensen et al., 2007
Thiolactomycin + PKS-NRPS Fatty acid synthesis inhibitor Tang et al., 2015
﻿Tirandalydigin + PKS-NPRS RNA polymerase inhibitor Castro-Falcón et al., 2016
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and that these functional patterns could be characteristics of ecotypes rather than due 
to geographical isolation (Jensen & Mafnas, 2006; Jensen et al., 2007; Penn et al., 2009). 
Lomaiviticin (Fig. 7) was the first molecule reported from Salinispora and was isolated 
from S. pacifica before the genus was actually formally described. The isolate from which 
lomaiviticin was discovered was indeed thought to be a new species of Micromonospora, 
until 16S analysis later revealed the strain to be S. pacifica (He et al., 2001; Janso et al., 
2014). Similarly to lomaiviticin, cyanosporaside and salinipyrone were two novel 
polyketides characteristic of S. pacifica, with the two formers exhibiting interesting 
cytotoxic activity (Oh et al., 2006, 2008). S. arenicola is the most widely distributed and 
abundant species of the genus (Fig. 6), and it is also a notable prolific producer of novel 
natural products (Table 1). For instance, the new polyketide molecules saliniquinone and 
arenimycin were both derived exclusively from S. arenicola and were found to have 
cytotoxic and antimicrobial activities, respectively (Asolkar et al., 2010; Murphy et al., 
2010). Interestingly, arenimycin (Fig. 7) was shown to be effective against rifampicin- and 
methicillin-resistant Staphylococcus aureus (MRSA), a growing threat to human health 
involved in the AMR crisis (Chua et al., 2011). The novel non-ribosomal peptide 
 





























































compounds retimycin and arenamide were also derived only from S. arenicola, and 
exhibited promising cytotoxic activity (Asolkar et al., 2009; Duncan et al., 2015).  
Among the catalogue of natural products discovered from Salinispora, salinosporamide 
is so far the most significant family of molecules obtained from the genus (Fig. 7; Gulder 
& Moore, 2010). Salinosporamide A was isolated from S. tropica in 2003, and has since 
then been extensively studied, leading to the identification of many analogues (Denora 
et al., 2007; Feling et al., 2003; Reed et al., 2007). The compound possesses a unique 
fused g-lactam-b-lactone bicyclic ring pharmacophore with potency to inhibit the 20S 
proteasome, a target in cancer chemotherapy (Crawford et al., 2011). For this reason, it 
quickly entered phase I clinical trials for the treatment of different myeloma under the 
name Marizomib, given by the FDA (Harrison et al., 2016; Macherla et al., 2005). Due to 
its lipophilic structure, which allows it to pass the blood-brain barrier, the 
biopharmaceutical company Celgene has acquired the rights to Marizomib in 2016, and 
is currently investigating the molecule’s potency to treat glioblastoma in a phase III 
clinical trial set to be completed in 2023 (ClinicalTrials.gov identifier NCT03345095). If 
salinosporamide is then approved, it will become the first marine natural product from 
a microbial source to be developed as a drug (Pereira, 2019). 
Salinispora has undisputedly provided a remarkable abundance of novel natural 
products so far, most of which are bioactive and clinically useful. It is clear, however, 
from sequencing and subsequent analyses of Salinispora’s genomes, that the 
biosynthetic potential of the genus still remains exceedingly underexplored as many 
identified biosynthetic loci encoding secondary metabolites await to be characterized. 
 
6. ORPHAN BIOSYNTHETIC GENE CLUSTERS 
Most secondary metabolites are biosynthesized by multi-modular enzyme complexes 
encoded by groups of genes co-localized in the genome, referred to as a biosynthetic 
gene clusters (BGCs). Based on the type of molecule produced, different classes of BGC 
exist, with NRPS- and PKS-type systems being the most widely characterized and 
responsible for the formation of nonribosomal peptides and polyketides, respectively 
(Fischbach & Walsh, 2006). These natural products are essentially constructed through 
the elongation of a chain of covalently bound building blocks, being acyl-coenzyme A 
(CoA) for polyketides and amino or carboxylic acids for nonribosomal peptides, following  
 23 
an assembly line logic allowed by functional domains organized within the BGC (Scott & 
Piel, 2019; Walsh, 2008). For instance, a type I modular PKS consists of multiple catalytic 
units called modules, each responsible for the incorporation of one monomer. The 
modules are themselves composed of core domains involved in the different steps of the 
assembly line, namely an acyltransferase (AT) domain, an acyl carrier protein (ACP) and 
a ketosynthase (KS) domain (Tibrewal & Tang, 2014). Briefly, the AT domain will select 
and load the acyl-CoA monomer onto the ACP, which tethers substrates and growing 
polyketide intermediates. The KS domain will then catalyse the condensation reactions 
to bind the nascent natural product and the extender unit (Khayatt et al., 2013). Similarly, 
a NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) and a 
condensation domain, which will serve analogous roles as the AT domain, the ACP and 
the KS domain, respectively (Fig. 8; Mootz et al., 2000). In addition to those biosynthetic 
genes required for the actual production of the molecule, BGCs also typically include 
 
Figure 8 | General organization of a NRPS assembly line. Each module is responsible for adding 
one amino-acid to the growing oligopeptide where the adenylation (A) domains select and 
activate amino-acids in a specific manner by converting them into their corresponding 
aminoacyl thioester, which will then be loaded onto the PCP domains. The condensation (C) 
domain catalyzes the formation of a peptide bond between the PCP-bound amino-acid and the 
growing peptide chain of the upstream module. The thioesterase (TE) domain releases the 
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genes involved in expression regulation, self-resistance and export of the produced 
compound (Corre et al., 2008; Medema et al., 2015; Tenconi & Rigali, 2018). 
Overall, the highly structured organization of BGCs facilitates their identification and 
characterization from the wealth of genomics data provided by next-generation 
sequencing technologies (Walsh & Fischbach, 2010). Genome mining of BGCs for natural 
product discovery has especially been propelled by the advent of bioinformatics 
pipelines such as antiSMASH, which allows fast identification and annotation of BGCs 
(Blin et al., 2019; Medema et al., 2011). More recently, the field has also seen the 
development of other platforms, like ARTS (Mungan et al., 2020) and BiG-
SCAPE/CORASON (Navarro-Muñoz et al., 2020), for the prediction of the mode of action 
of BGC-encoded compounds via the identification of antibiotic resistant genes and for 
the clustering and classification of BGCs. While allowing the discovery of many novel 
natural products, these extensive genome mining efforts have simultaneously revealed 
an intriguing fact – a typical actinobacteria has the genetic potential (i.e. BGCs) to 
produce on average 10 times more secondary metabolites than what had been detected 
Table 2 | Biosynthetic gene clusters of Salinispora tropica CNB-440. Table shows the 
characterized (orange) and orphan (green) BGCs of S. tropica CNB-440.  
 
BGC name Biosynthetic class Product Genetic location(strop_) Size (kb) Reference
sal polyketide/non-ribosomal peptide salinosporamide RS05130-RS05275 41.8 Feling et al., 2003
lom polyketide lomaiviticin RS10930-RS11215 62.2 Kersten et al., 2013
des hydroxamate desferrioxamine RS12775-RS12855 19.2 Roberts et al., 2012
spo polyketide sporolide RS13560-RS13730 49.2 Dineshkumar et al., 2014
slm polyketide salinilactam RS13850-RS13965 82.0 Udwary et al., 2007 
lym polyketide/non-ribosomal peptide lymphostin RS15295-RS15350 25.0 Miyanaga et al., 2011
terp1 terpenoid sioxanthin RS16250-RS16295 10.4 Richter et al., 2015
spt butyrolactone salinipostin RS20900-RS20940 11.1 Amos et al., 2017
terp2 terpenoid sioxanthin RS22405-RS22445 11.7 Richter et al., 2015
pks1 polyketide NA RS02980-RS03095 30.9 NA
nrps1 non-ribosomal peptide NA RS03375-RS03535 37.5 NA
amc carbohydrate NA RS11765-RS11795 6.6 NA
bac1 ribosomal peptide NA RS11800-RS12275 19.2 NA
pks3 polyketide NA RS12510-RS12630 23.3 NA
sid2 non-ribosomal peptide NA RS13260-RS13385 40.7 NA
sid3 non-ribosomal peptide NA RS13985-RS14120 29.2 NA
sid4 non-ribosomal peptide NA RS14125-RS14260 40.8 NA
bac2 ribosomal peptide NA RS14265-RS15290 19.0 NA
pks4 polyketide NA RS21120-RS21540 10.0 NA
nrps2 non-ribosomal peptide NA RS22250-RS22350 34.7 NA
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from traditional screening and chemical analysis (Palazzotto & Weber, 2018). Those 
biosynthetic loci that are detected bioinformatically but for which no natural product has 
been assigned yet are called orphan BGCs. It is generally considered that they are either 
transcriptionally silent (i.e. poor or conditional level of expression or inactivation of their 
biosynthetic genes) or that the molecules they produce are difficult to detect and isolate 
(i.e. compound instability, limited sensitivity of detection methods or absence of 
bioactivity to screen for) (Rutledge & Challis, 2015). 
The significance of orphan BGCs as a tremendous and untapped resource of novel 
bioactive compounds is well exemplified in the genus Salinispora. A recent study 
analyzing the draft genomes of 119 strains showed that, among the 176 distinct BGCs 
bioinformatically identified, a staggering 80% of those were still orphan (Letzel et al., 
2017). As an illustrative case, the genome of the type strain S. tropica CNB-440 harbors 
at least twenty putative BGCs, but of these, only nine have been assigned to a natural 
product so far (Table 2). Discovering new secondary metabolites from the remarkable 
pool of orphan BGCs that remain to be characterized has become a focus of natural 
product research, with the development of means to activate such silent clusters being 
one of the biggest challenges of these research efforts (Onaka, 2017; Ren et al., 2017). 
 
7. UNLOCKING MICROBIAL BIOSYNTHETIC POTENTIAL 
In response to the growing number of orphan BGCs reported, researchers have 
developed pleiotropic and pathway-specific approaches to activate those silent clusters 
(Rutledge & Challis, 2015). Some successful examples of pathway-specific methods 
include the expression of entire BGCs in a heterologous host and the manipulation of 
transcription factors activating their expression. For instance, capture of a silent NRPS 
cluster from the marine actinomycete Saccharomonospora using transformation-
associated recombination (TAR) cloning, followed by the deletion of a regulatory gene 
and subsequent expression of the refactored cluster into the host S. coelicolor, resulted 
in the discovery of the antibiotic taromycin (Yamanaka et al., 2014). A recent study from 
our group similarly used TAR cloning to capture a silent gene cluster from a genetically 
intractable Streptomyces strain, before inactivating a transcriptional repressor via 
CRISPR/Cas9 editing to trigger the production of scleric acid in Streptomyces albus 
(Alberti et al., 2019). Although these pathway-specific approaches have proven 
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successful, their implementation can present several limitations as they require the BGC 
of interest to be: (i) controlled by an identifiable transcription factor, (ii) amenable to 
genetic manipulation and (iii) of a reasonable size (<40 kb), as methods for capture and 
heterologous expression typically become less efficient as the size of the cluster 
increases (Rutledge & Challis, 2015). Additionally, such methods are by definition 
targeted and can hardly be applied in a high throughput manner or when little is known 
about the BGCs and their regulation.  
In contrast, pleiotropic approaches can be used to trigger global changes in the 
regulation of biosynthetic loci, regardless of their sizes and without requiring any prior 
knowledge on their genetics, and do so in genetically intractable organisms. Most natural 
products are specialized molecules resulting from the myriad of inter- and intraspecies 
interactions that occur in the natural environment of the producing organisms. When 
they are grown axenically in vitro, many of the activating signals (e.g. signalling 
molecules, nutrients or cell-cell contacts) are therefore absent, leading to silent BGCs. 
Consequently, one of the most efficient and fruitful pleiotropic methods described in the 
literature utilizes co-cultivation of different microbes to elicit novel secondary 
metabolite biosynthesis (Bertrand et al., 2014; Slattery et al., 2001; Wakefield et al., 
2017). Finally, the advent of -omics technologies (i.e. genomics, transcriptomics, 
proteomics etc.) have been instrumental in improving our understanding of secondary 
metabolites pathways and the discovery of new natural products (Bumpus et al., 2009; 
Chen et al., 2013; Palazzotto & Weber, 2018). 
While these different methods have been applied successfully to various microorganisms 
and especially to Streptomyces sp. (Abdelmohsen et al., 2015; Onaka, 2017; Reen et al., 
2015; Rutledge & Challis, 2015), their use in the genus Salinispora remains in its infancy. 
To the best of our knowledge, only a couple of studies employed heterologous 
expression of silent BGCs from S. pacifica and S. arenicola into Streptomyces host strains, 
to uncover the compounds enterocin and isopimara-8,15-dien-19-ol, respectively (Bonet 
et al., 2015; Xu et al., 2014). The co-inoculation of Salinispora with other microbes has, 
on the other hand, been more used but with little success. For instance, growing S. 
arenicola with the fungus Emericella sp. induced the production of the molecule 
emericellamide but in the latter instead of the former (Oh et al., 2007). More recently, 
Patin and colleagues co-cultured different S. arenicola and S. tropica strains with various 
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marine heterotrophs isolated from sediments but these interactions did not yield any 
new natural product (Patin et al., 2018; Patin et al., 2016). They showed, however, that 
S. tropica intriguingly exhibited antimicrobial activities against some marine 
heterotrophs without being able to identify the killing agent. These studies notably 
provided a first insight on the ecological significance of the bioactive compounds issued 
from members of the genus Salinispora and of their interactions with the microbial 
communities residing in marine sediments (Patin et al., 2017). Lastly, comparative 
transcriptomics analysis of several strains of Salinispora resulted in the discovery of the 
salinipostin molecule in S. pacifica (Amos et al., 2017) but it is so far the only study of the 
type in the genus. 
 
8. CONCLUSION 
The alarming increase of AMR has brought to light the urgency with which we need to 
discover novel active compounds, while the recurring rediscovery of already known 
natural products has drawn the interest of researchers towards untapped ecological 
niches to isolate unique molecules (Bull & Goodfellow, 2019). The marine 
actinobacterium Salinispora certainly drew particular attention upon its isolation almost 
two decades ago. The study of its secondary metabolome has since proven the genus to 
be an exceptional source of novel and bioactive natural products, set to rival the 
significance of soil actinomycetes (Jensen et al., 2015).  
The discovery of new small molecules from Salinispora and other microbes is, however, 
currently hampered because most BGCs encoded by these microorganisms are not 
expressed under standard laboratory conditions (i.e. monocultures) (Walsh & Fischbach, 
2010). This derives, in part, from our poor understanding of their natural interactions 
within their environments. The astonishing proportion of these orphan BGCs in 
Salinispora warrants the development of untried approaches to unlock the biosynthetic 
potential of the genus. Also, although a few studies investigated Salinispora’s impact on 
heterotrophic bacterial communities in marine sediments (Patin et al., 2017), very little 
is known of its interactions with other microbial communities (i.e. phototrophs), while 
there is growing evidence that Salinispora has a more cosmopolitan ecological 
distribution than what was previously thought (Ocampo-Alvarez et al., 2020).  
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RESEARCH AIMS FOR THE PH.D. THESIS 
The present Ph.D. thesis aimed at exploring novel ways to activate, interrogate, and 
manipulate the biosynthetic potential of the marine actinobacterium S. tropica CNB-440.  
 
The objectives of the research carried out were thus threefold. 
  
 
§ Firstly, to investigate the potency of co-culturing marine phytoplankton with 
Salinispora to stimulate its biosynthetic activity, using metabolomics. 
 
§ Secondly, to identify expression of candidate BGCs using high-throughput 
proteomics. 
 
§ Thirdly, to establish new strategies to influence secondary metabolite production 
in Salinispora at the genetic level, using the genome engineering CRISPR/Cas9 
technology for multiple-gene deletion. 
 
 
The following chapters will introduce the results obtained from these three research 
objectives. 
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2006, 2007, 2008; Richter et al., 2015; Roberts et al., 2012b; Schlawis et al., 2018; Schultz 
et al., 2008, 2010; Schulze et al., 2015; Tang et al., 2015; Udwary et al., 2007; Villadsen 
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INTRODUCTION 
Soil actinomycetes are a rich source of drug-like natural products, to which we owe up 
to 70% of all microbial antibiotics used today (Bérdy, 2012). Identification of novel 
secondary metabolites from this extensively studied family has, however, stalled over 
the last few decades as a result of the recurring rediscovery of already known 
compounds. This has led in recent years to a thriving interest for the study of new 
microorganisms, with the rationale that ecologically distinct microorganisms produce 
equally distinct secondary metabolites (Bull & Goodfellow, 2019; Molinski et al., 2009; 
Wilson & Brimble, 2009). For instance, the heterotrophic bacteria Salinispora drew 
particular attention when discovered as it was the first obligate marine actinomycete 
described (Jensen et al., 1991; Mincer et al., 2002) and has since proven to be an 
important source of new natural products for the pharmaceutical industry (Asolkar et al., 
2010; Buchanan et al., 2005; Feling et al., 2003; Maldonado et al., 2005).  
Despite the increasing number of novel strains identified with promising biosynthetic 
capacities, many hurdles in natural product discovery remain. Most of these microbial 
secondary metabolites are encoded by groups of colocalized genes, called biosynthetic 
gene clusters (BGCs), which are now more easily identified because of the improvement 
in sequencing technologies and bioinformatic tools (Medema et al., 2011). The majority 
of these identified BGCs, however, have yet to be linked to their products and are called 
orphan BGCs. They are generally considered to be either silent - because of a low level 
of expression or inactivation of their biosynthetic genes - or the metabolites they 
produce are cryptic - difficult to detect and isolate (Reen et al., 2015; Rutledge & Challis, 
2015). The observation of numerous orphan BGCs in genome-sequenced 
microorganisms has resulted in a growing interest in developing biological or chemical 
means to activate such clusters (Abdelmohsen et al., 2015; Onaka, 2017). One of the 
simplest and most efficient methods described in the literature relies on co-cultivation 
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of different microbes to elicit novel natural product biosynthesis (Bertrand et al., 2014; 
Slattery et al., 2001; Wakefield et al., 2017). 
The genome of the marine actinomycete Salinispora tropica comprises at least 20 
putative BGCs of which 11 are orphan (Penn et al., 2009; Udwary et al., 2007). Recent 
studies have shown that Salinispora co-inoculated with various marine heterotrophs 
could produce one or several antimicrobial compounds, which remain uncharacterized 
as traditional analytical chemistry methods did not allow their identification and no 
candidate BGC was proposed (Patin et al., 2018; Patin et al., 2016). While co-culturing 
appears to be a promising means to activate orphan BGCs in Salinispora, it remains an 
underexplored technique to unravel the biosynthetic potential of this genus.  
Here we report the discovery of novel cryptic secondary metabolites produced by S. 
tropica CNB-440. By using state-of-the-art metabolomics, we investigated how marine 
microbial phototrophs and their photosynthate induce the production of new 
metabolites in S. tropica. This strategy confirms microbial interactions as a promising and 
simple approach for future discovery of novel natural products. 
 
MATERIAL AND METHODS 
1. Culture conditions and cell abundance monitoring 
1.1. Strains and growth media 
Axenic marine phototrophs Synechococcus sp. WH7803, Emiliania huxleyi RCC1242 and 
Phaeodactylum tricornutum CCAP1055/1 were routinely grown in Artificial Seawater 
(ASW, Wilson et al., 1996), K-media (Probert & Houdan, 2004), and F/2 media (Guillard, 
1975), respectively. Cultures were set up in Falcon 25 cm² rectangular culture flasks with 
vented caps containing 20 mL of media and incubated at a constant light intensity of 10 
μmol photons m-2 s-1, at 22 °C with orbital shaking (140 rpm). The type strains Salinispora 
tropica CNB-440T (DSM No. 44818), Salinispora arenicolaT CNH-643 (DSM No. 44819) and 
Salinispora pacifica CNR-114 (DSM No. 45546) were grown in marine broth (MB, Difco), 
and incubated at 30 °C with orbital shaking (220 rpm). The S. tropica mutants salA- and 
salL- were generously provided by the Moore Laboratory, USA (Eustáquio et al., 2009; 
Eustáquio & Moore, 2008). Marine broth was supplemented with 50 μg mL-1 apramycin 
or 1.1 g L-1 Tris base, when required. ASW was supplemented with 10 μg mL-1 rifamycin 
SV or 3, 10, 50 or 100 μg mL-1 Fe(III), as required. 
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1.2. Co-culture setup 
Salinispora cells were grown to late exponential phase in 10 mL of MB before washing 
them three times with sterile mineral media, as appropriate for each phototroph, and 
finally resuspending the washed cell pellet in 10 mL of mineral media. Exponentially 
growing axenic phototroph cells and the washed Salinispora were co-inoculated in fresh 
media to a concentration of 10% (v/v) and 20% (v/v), respectively. Salinispora cells were 
also washed and resuspended in a conditioned Synechococcus supernatant (SUPSYN), 
when required for the metabolomic analyses. To obtain the conditioned supernatant, 
Synechococcus cultures were incubated for 35 days as described above before 
centrifugation (4000 x g for 10 minutes at room temperature) and further filtration 
through 0.22 µm pore size filters to remove cells and particulate organic matter. Washed 
Salinispora cells were used to inoculate SUPSYN and MB, and cultures were incubated at 
22 °C with shaking (140 rpm) and a light intensity of 10 μmol photons m-2 s-1. For the 
physically separated Synechococcus-Salinispora co-cultures using the porous filters, cells 
were grown in 24 mm transwell with 0.4 μm pore polycarbonate membrane inserts 
(Corning). Synechococcus cells were inoculated in the well to a concentration of 20% (v/v) 
and Salinispora in the insert to a concentration of 55% (v/v). 
 
1.3. Flow cytometry 
Phototroph cell abundance was monitored using their autofluorescence by flow 
cytometry using a LSR Fortessa Flow Cytometer (BD) instrument, and the BD FACSDiva 
acquisition software (BD). Cells were detected and gated using excitation 488 nm – 
emission 710/50 nm at voltage 370 V, and ex. 640 nm – em. filter 670/14 nm at voltage 
480 V. To remove any Salinispora cell aggregates that would block the flow cell, samples 
were pre-filtered through a sterile mesh with pore size of 35 μm (Corning) prior to 
analysis. 
 
2. Metabolomic analysis 
2.1. Sample preparation 
The culture supernatants were analyzed by non-targeted metabolomic using either raw 
or concentrated supernatants. Raw supernatants were collected by sampling 200 μL of 
0.22 μm-filtered culture milieu, prior to being mixed with an equal volume of HPLC-grade 
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methanol. For concentrating the supernatant, cells from 10 to 100 mL of cultures were 
removed by centrifugation (4,000 x g for 15 minutes) followed by a filtering step using 
0.22 μm vacuum filter bottle system (Corning). Pre-purification of the compounds of 
interest from the supernatants was carried out by solid phase extraction using C18-silica. 
Using a 90:10 A/B mobile phase (where A is water with 0.1% formic acid and B is 
methanol with 0.1% formic acid) the undesired polar molecules and salts passed through 
the silica while the compounds of interest were retained and later collected following 
elution with a 10:90 A/B mobile phase. The obtained fractions were dried under reduced 
pressure at 40 °C (in a speed-vac) and resuspended in 1-3 mL of 50:50 HPLC-grade 
methanol/water solution. All samples were stored in snap-seal amber glass vials (Thames 
Restek) and kept at -20 °C until analysis. 
 
2.2. Low-resolution LC-MS 
Metabolites present in the cultures were routinely analyzed by reversed-phase liquid 
chromatography (LC). A Dionex UltiMate 3000 HPLC (ThermoScientific) coupled with an 
amaZon SL Ion Trap MS (Bruker) was used. A Zorbax Eclipse Plus C18 column with 
dimensions 4.6 mm x 150 mm, 5 μm particle size (Agilent Technologies) was employed 
for metabolite separation with a linear gradient of 95:5 A/B to 30:70 A/B over 5 minutes, 
followed by second linear gradient to 20:80 A/B over 10 minutes with a flow rate of 1 mL 
min-1 (Mobile phase A: water with 0.1% formic acid, B: methanol with 0.1% formic acid). 
The mass spectrometer (MS) was operated in positive ion mode with a 100-1000 m/z 
scan range. The injected volume was 10 μL at a temperature of 25 °C. Data was processed 
with the Bruker Compass DataAnalysis software version 4.2 (Bruker). 
 
2.3. High-resolution LC-MS 
To acquire molecular formulae information, samples were analyzed using an Ultra-high 
resolution MaXis II Q-TOF mass spectrometer equipped with electrospray source 
coupled with Dionex 3000RS UHPLC was employed (Bruker). A reverse phase C18 column 
(Agilent Zorbax, 100x2.1 mm, 1.8 μm) and a guard column (Agilent C18, 10x2.1 mm, 1.8 
μm) were used for separation applying a linear gradient of 95:5 A/B to 0:100 A/B over 20 
minutes (Mobile phase A: water with 0.1% formic acid, B: acetonitrile with 0.1% formic 
acid). The injected volume was 2 μL, and the flow rate was 0.2 mL min-1. At the beginning 
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of each run, 7.5 μL of 10 mM of sodium formate solution was injected for internal 
calibration. The mass spectrometer was operated in positive ion mode with a 50-2500 
m/z scan range. MS/MS data was acquired for the three most intense peaks in each scan. 
 
3. Isolation and bioactivity assay of metabolites 
3.1. Metabolites purification by HPLC  
For metabolite purification for Nuclear Magnetic Resonance (NMR) analysis, organic 
extracts of co-cultures grown for 35 days were prepared as described in sections 1.2. and 
2.1., with the following modifications: (i) four litres of co-cultures were obtained as 40 
independent 100-mL cultures implemented in 250-mL conical flasks. Cultures were 
incubated for 35 days at 22 °C with shaking (140 rpm) and a light intensity of 10 μmol 
photons m-2 s-1; (ii) Following pre-purification of the compounds by C18-silica solid phase 
extraction, the obtained extracts were dissolved in ca. 6 mL of 50:50 HPLC-grade 
methanol/water solution. 
The isolation of molecule 6 from the organic extract was performed by reverse-phase 
HPLC, with a time-based pre-purification step followed by a UV-VIS-based separation 
step. An Agilent 1200 HPLC equipped with a binary pump and a Diode-Array Detector 
(DAD) was used. An Agilent Prep-C18 column with dimension 21.2 mm x 150 mm, particle 
size 5 μm (Agilent Technologies) was employed for metabolite separation with a linear 
gradient of 50:50 A/B to 20:65 A/B over 24 minutes with a flow rate of 5 mL min-1 (Mobile 
phase A: water with 0.1% formic acid, B: methanol with 0.1% formic acid). Samples were 
run as several rounds of 1,500 μL injected volume. The fraction containing the cryptic 
molecule 6 was collected between 2 to 6 minutes in the run, using an automated fraction 
collector. The resulting fraction was dried under reduced pressure at 40 °C (in a speed-
vac) and resuspended in 600 μL of 50:50 HPLC-grade methanol/water solution.  
Molecule 6 was further purified from the obtained sample by absorbance at 310 nm from 
8.5 to 10 minutes in the run, using the same linear gradient as above. Sample was run as 
several rounds of 400 μL injected volume. Between runs, 50:50 HPLC-grade 
methanol/water solution was added to the ~200 μL of dead volume left from the sample 
to restore the 600 μL volume. Dilution was repeated up to four times. The threshold of 
the DAD for collection was set to values ranging from 15 to 500 mAU, as appropriate for 
the sample. 
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3.2. Bioactivity assay of organic fractions 
The fractionation of organic extracts, obtained as explained in section 2.1 from 20-mL 
cultures, was done using reverse-phase HPLC. An Agilent 1200 HPLC equipped with a 
binary pump was used. An Agilent Prep-C18 column with dimension 21.2 mm x 150 mm, 
particle size 5 μm (Agilent Technologies) was employed for metabolite separation with a 
linear gradient of 50:50 A/B to 20:80 A/B over 25 minutes with a flow rate of 5 mL min-1 
(Mobile phase A: water with 0.1% formic acid, B: methanol with 0.1% formic acid). 
Fractions were collected with 2 minutes time slices, using an automated fraction 
collector. Samples were run as several rounds of 1,500 μL injected volume. Matching 
fractions were pooled and dried under reduced pressure at 40 °C (in a speed-vac) and 
resuspended in 200 μL of sterile ASW, resulting in 12 fractions concentrated 100X. 
To test the culture extract-issued fractions for bioactivity, exponentially growing axenic 
Synechococcus cells were inoculated in 5 mL of fresh ASW to a concentration of 10% 
(v/v). The resulting cultures were spiked with 200 μL of either ASW, or a 100X HPLC-
fraction, for a final concentration of 4X. Cells were incubated at 22 °C with shaking (140 
rpm) and a light intensity of 10 μmol photons m-2 s-1. 
 
3.3. Disc diffusion test 
The 50X organic extracts used for the assay were generated as explained in section 2.1 
from 20-mL cultures, and resuspended in a final volume of 400 μL of 50:50 HPLC-grade 
methanol/water solution. To grow phototrophic cells into solid media, 40 mL of 
exponentially growing axenic Synechococcus cells were first concentrated by 
centrifugation (4,000 x g for for 5 minutes), before discarding the supernatant. Cells were 
resuspended in the remaining media (~200 μL) and mixed together with 20 mL of freshly 
autoclaved ASW-0.2% agarose (still liquid). The cell-medium mixture was poured into 
plates and let to set/dry for 2 hours prior to being used. Autoclaved antibiotic assay discs 
(diam. 6 mm, Whatman) were coated with either an axenic Synechococcus culture 
organic extract (50X), a Salinispora-Synechococcus co-culture organic extract (50X), 10 
μg mL-1 gentamycin or ASW with 1% methanol. Coated discs were placed onto the 
inoculated plates using flamed-sterilized tweezers. Plates were incubated at 22 °C under 
a light intensity of 10 μmol photons m-2 s-1. 
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Figure 9 | S. arenicola and S. tropica have antimicrobial activity on Synechococcus in co-culture. 
(A) Synechococcus grown in axenic culture and in co-culture with three species of Salinispora. 
Photographs of representative cultures of three biological replicates are shown. Red pigmentation 
is characteristic of healthy Synechococcus cells, while cell bleaching (white cultures) indicates dead 
cells. (B) Synechococcus is sensitive to rifamycin. Synechococcus cell count over time in culture 
media with 0 (red line) or 10 (blue line) µg mL-1 of the antibiotic rifamycin. Graph shows mean ± 
standard deviation of three biological replicates. 
 
RESULTS 
Salinispora tropica has antimicrobial activity on a diverse range of marine phototrophs 
We co-inoculated the cyanobacterium Synechococcus sp. WH7803 with three 
representative species of the genus Salinispora, namely Salinispora arenicola, Salinispora 
pacifica and Salinispora tropica. Unlike other heterotrophs, which usually enhance the 
growth of phototrophic organisms when in co-culture (e.g. Christie-Oleza et al., 2017; 
Sher et al., 2011), both S. arenicola and S. tropica showed a clear antimicrobial activity 
against Synechococcus (Fig. 9, A). Although we were able to monitor the phototroph’s 
inhibition, we were unable to assess the growth profile of Salinispora in the co-culture 
due to its growth as dense cell aggregates preventing traditional monitoring techniques 














































































































































to biosynthesize the antibiotic rifamycin (Asolkar et al., 2010), to which we confirmed 
Synechococcus is sensitive (Fig. 9, B), no antimicrobial compound has yet been 
characterized in S. tropica CNB-440. We were therefore interested in characterizing the 
nature of Synechococcus growth inhibition by S. tropica.  
 
Figure 10 | Synechococcus inhibition by S. tropica is not mediated by iron or nutrient depletion. 
(A) Monitoring of Synechococcus population grown axenically or in co-culture with S. tropica, in 
media supplemented with 3, 10, 50 or 100 mg L-1 Fe(III). Graph shows mean ± standard deviation 
of three biological replicates. (B) Synechococcus grown axenically in a conditioned supernatant 
(right panel), obtained from a Synechococcus-Salinispora co-culture after the death of the 
phototroph (left panel). Photographs of representative cultures from three biological replicates 
are shown. Red pigmentation is characteristic of healthy Synechococcus cells, while cell bleaching 
(white cultures) indicates dead cells. 
 
Previous studies have shown that S. tropica is able to outcompete other heterotrophs in 
co-culture by secreting the siderophore desferrioxamine leading to iron depletion (Patin 
et al., 2016; Roberts et al., 2012). To evaluate whether iron sequestration could explain 






























































supplemented the co-cultures with increasing concentrations of iron (Fig. 10, A). The 
results obtained suggest that the antimicrobial phenotype was not due to siderophore 
activity, as saturating amount of iron could not rescue the growth of the phototroph.  
We also assessed whether general nutrient depletion by S. tropica could be responsible 
for the phototroph growth defect. For this, we incubated S. tropica and Synechococcus 
together until bleaching of the latter. Remaining cells were filtered out to obtain a sterile 
 
Figure 11 | Salinispora tropica inhibits the growth of several phytoplankton via the secretion of an 
antimicrobial molecule. (A) Synechococcus growth inhibition by S. tropica mediated by a diffusible 
molecule. The cyanobacterium was grown axenically and in co-culture with S. tropica, separated 
by a 0.4 µm pore membrane insert. Photographs of representative cultures of three biological 
replicates are shown, 7 days after inoculation. Red pigmentation is characteristic of healthy 
Synechococcus cells, while cell bleaching indicates cell death. (B) S. tropica inhibits marine 
phototrophs growth in co-culture. Cultures of three marine phototrophs grown axenically (red 
lines) and in co-culture with Salinispora tropica (blue lines). Graph shows mean ± standard 
deviation of three biological replicates. Statistically significant cell abundance are indicated (T-test, 























































































































conditioned supernatant, in which we inoculated axenically fresh Synechococcus cells 
(Fig. 10, B). The conditioned supernatant allowed rapid growth of the phototroph, 
suggesting that nutrient depletion did not drive the death of the first Synechococcus cells 
co-inoculated with S. tropica in this medium.  
We then hypothesized that a yet unknown antimicrobial compound, to which our 
photosynthetic microorganism is sensitive to, could be produced by S. tropica. To test 
this assumption, we setup co-cultures in which S. tropica and Synechococcus were 
physically separated by a porous filter, preventing direct cell-to-cell interactions while 
allowing the diffusion of small molecules (Fig. 11, A). S. tropica was still able to impair 
Synechococcus proliferation in these experimental conditions, confirming that a secreted 
molecule was causing the death of the phototroph.  
We were interested in testing the efficacy of this secreted compound against different 
types of phytoplankton. We therefore co-inoculated S. tropica with three phototrophic 
model species, namely the cyanobacterium Synechococcus sp. WH7803, the 
coccolithophore Emiliania huxleyi and the diatom Phaeodactylum tricornutum. They all 
showed a strong decline in the presence of S. tropica, being especially remarkable for 
the two former species (Fig. 11, B). While also affected, the diatom P. tricornutum was 
not killed by S. tropica but, instead, its cells densities were significantly maintained one 
order of magnitude lower than when incubated axenically. Altogether, our observations 
revealed that S. tropica produced a yet unknown antimicrobial molecule effective against 
both eukaryotic and prokaryotic phytoplankton. 
 
Phototrophs elicit the production of novel cryptic metabolites in S. tropica  
We analyzed the co-culture supernatants using non-targeted metabolomics to identify 
the pool of secondary metabolites secreted by S. tropica in response to the different 
phototrophs. The Synechococcus-S. tropica co-culture revealed eight molecular ions that 
were not present in the respective axenic cultures (Fig. 12, A). These molecules were 
further characterized by high-resolution MS/MS analysis, from which we generated 
empirical chemical formulae, allowing us to assign most of them to two subgroups of 
related compounds being: (i) ions 1, 2, 5 and 8; and (ii) ions 4, 6 and 7 (Fig. 12, B). 
Ions 1, 2, 5 and 8 were derivatives of salinosporamide; a well-characterized molecule 




Figure 12 | Metabolome of the S. tropica-Synechococcus co-cultures. (A) S. tropica produces 
detectable small molecules in co-culture with Synechococcus. Overlaid base peak 
chromatograms (BPCs) of Synechococcus culture concentrated supernatants, when grown for 
35 days in artificial sea water (ASW) either axenically (red) or in co-culture with S. tropica (blue). 
Peaks characteristic of the co-culture condition are labelled from 1 to 8. Color of the labels 
indicate groups of related compounds. (B) Molecular ions detected by LC-MS in S. tropica-
Synechococcus co-culture. Table shows molecular ions detected by high-resolution LC/(+)ESI-
MS. Peak numbering is based on HPLC retention time and colors indicate groups of related 
compounds. Observed m/z values and predicted chemical formulae for [M+H]+ are provided. 
Observed mass of main ions obtained after MS2 fragmentation are given. 
MS Peak Observed m/z Chemical formulae for [M+H]
+
(calculated m/z; err [ppm]) MS/MS
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(449.2758; -1.3) 156.1135




























-cture (Feling et al., 2003), and that is now being tested as a drug because of its anti-
cancer properties. Molecules 5 and 8 are consistent with known degradation products 
of salinosporamide A and B, respectively (Denora et al., 2007; Fig. 13), while molecules 
1 and 2 are proposed to result from the nucleophilic addition of Tris (the buffering agent 
used in the ASW culture medium) to the lactone ring of salinosporamide A and B, 
respectively (Fig. 13). These salinosporamide sub-products were further confirmed by 
their absence when (i) Tris was not added (Fig. 14, A), or (ii) salinosporamide mutants 
that no longer produced these metabolites, i.e. salA- and salL-  (Eustáquio et al., 2009), 
were used (Fig. 14, B). In order to test the activity of salinosporamide and its derivatives 
 
Figure 13 | Chemical structure of salinosporamide A and B, with their respective degradation 
products. Salinosporamide A (C15H2035ClNO4; mass 313.11) either hydrolyzes to form the 
molecule NPI-0065, 5 (C15H21NO5; mass 295.14) or reacts with Tris to form the hypothetical 
molecule 1 (C19H30N2O7; mass 398.21). Salinosporamide B (C15H21NO4; mass 279.15) either 
hydrolyzes to form the molecule 8 (C15H23NO5; mass 297.16) or reacts with Tris to form the 





















on the phototrophs, we co-cultured Synechococcus with both salinosporamide mutants. 
Salinosporamide and its derivatives were not responsible for the antimicrobial activity as 
both deficient mutants were still able to inhibit the phototroph (Fig. 15). 
 
Figure 14 | Molecules 1, 2, 5 and 8 are degradation products of the analogs salinosporamide 
A and B. (A) Culture supernatant of S. tropica grown in marine broth (top panel) or marine 
broth supplemented with Tris (bottom panel). In red is shown the extracted ion 
chromatogram for molecule 1, with m/z 399 (± 0.5). In orange is shown the extracted ion 
chromatogram for molecule 5, with m/z 296 (± 0.5). (B) Extracted ion chromatograms of 
molecules 1, 2, 5 and 8 (EIC 399; 401; 296; 298 ± 0.5) in the culture supernatant of S. tropica 
wild-type (top panel), and the salinosporamide mutants salA- (middle panel) and salL- 
(bottom panel). The salA- strain does not produce salinosporamide A or any derivatives, while 




The second group of ions i.e. peaks 4, 6 and 7, were also related. Molecule 6 gave a m/z 
value of 435.2609 [M+H]+. Based on the accuracy of this value and the isotopic pattern 
the empirical chemical formula C22H35N4O5 was predicted by the DataAnalysis software. 
The predicted formula for molecule 4 suggests that, with a 28.9900 Da mass difference 
when compared to 6, the compound had lost one hydrogen and gained one nitrogen and 
one oxygen (Fig. 16). MS/MS analyses confirmed that both molecules 4 and 6 had an 
identical molecular fragment (i.e. m/z 276.1600 ± 0.0001 [M+H]+, with the empirical 
chemical formula C16H22NO3), indicating that the two molecules share a core backbone 
(Fig. 16; Appendix 2). Similarly, molecule 7 had the same chemical formula as 6 but with 
the addition of a methyl group (14.0155 Da mass difference; Fig. 16). Finally, MS/MS 
fragmentation of the three molecules 4, 6 and 7 resulted in the related molecular 
fragments m/z 171.088, 142.0979 and 156.1135, respectively, which showed differences 
in masses and empirical formulae identical to that observed between their 
corresponding parent ions (Fig. 16; Appendix 2). Molecule 3 did not share an obvious 
link to any other metabolites and, therefore, was considered a new biosynthesized 
product of Salinispora (Fig. 12, B). Most interestingly, the search for compounds with the 
same molecular formulae as 3, 4, 6 or 7 in multiple databases (e.g. Reaxys, SciFinder, 
 
Figure 15 | Monitoring of Synechococcus grown in axenic culture and in co-culture with the wild-
































Dictionary of NP) returned no known natural product, suggesting that they are novel 
compounds. 
Intriguingly, the production of these novel compounds was triggered by the presence of 
the phototrophs as they were only detected in the co-cultures of all three phototrophs 
(Fig. 12, A; Fig. 17, A), but not when grown in mono culture – as shown by the absence 
of these metabolites when S. tropica was grown alone in mineral ASW or nutrient rich 
media MB (Fig. 17, B and C). Furthermore, we confirmed that the supernatant of a 
phototroph culture – containing photosynthate – was enough to induce such metabolite 
production (Fig. 17, C). 
 
 
Figure 16 | The cryptic molecules 4, 6 and 7 are related. Schematic of the cryptic compounds 
and their corresponding daughter ions generated by MS/MS. Observed m/z values detected by 
high-resolution LC/(+)ESI-MS and predicted chemical formulae for [M+H]+ are provided. N/A 
indicate chemical formulae that could not be generated by the DataAnalysis software. 
 
The cryptic compounds have a characteristic 310 nm absorbance spectrum 
In order to characterize the cryptic molecules, we were interested in testing whether 
they had antimicrobial activity. For this, fractions obtained from high-pressure liquid 












































were spiked into axenic Synechococcus cultures but none exhibited antimicrobial activity 
against the phototroph (Fig. 18, A), although we confirmed that the cryptic molecule 6 
was present in the fraction 2 (Appendix 3). We hypothesized that the synergistic effect 
of multiple molecules could be required to observe antimicrobial effect and/or that 
instability of the antimicrobial compounds could lead to low concentrations and prevent  
 
Figure 17 | Marine phototrophs trigger the production of cryptic molecules in S. tropica. (A) 
Other marine phototrophs also trigger the production of metabolite 6 by S. tropica as observed 
in Fig. 12, A. Figure shows extracted ion chromatograms for the molecule 6 EIC 435.2 ± 0.1 in 
the supernatants of the phototrophs (P. tricornutum, top panel; E. huxleyi, bottom panel) 
grown axenically (red) and in co-culture with S. tropica (blue). (B) The production of the related 
molecules 4, 6 and 7 is dependent on the presence of photosynthate rather than high-nutrient 
availability. Graph shows extracted ion chromatograms for all three cryptic molecules EIC 
(464.2; 435.2; 449.2) ± 0.5 in the concentrated supernatants of S. tropica grown axenically for 
35 days in marine broth (S. tropica MB, red) or in co-culture with Synechococcus in ASW (Co-
culture, blue). (C) Cryptic molecule production is triggered by nutrients released by 
Synechococcus rather than cell-to-cell interactions. Graph shows extracted ion chromatograms 
for the cryptic molecule 6 (EIC 435.2 ± 0.5) in the supernatant of S. tropica grown axenically for 
14 days either in artificial sea water (ASW, black line) or in a conditioned Synechococcus 
supernatant (SUPSYN, green line); and in co-culture with Synechococcus (Co-culture, red line). 
SUPSYN is equivalent to the ‘Synechococcus Axenic’ condition in Fig. 12, A; cryptic metabolites 
were only detected after S. tropica incubation. 
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their activity. In an attempt to address these potential issues, we performed a disc 
diffusion assay against Synechococcus growing onto solid media, using a crude organic 
extract of the co-culture supernatant. We reasoned that this assay minimized dilution  
 
Figure 18 | Bioactivity-guided assays of co-culture organic extracts. (A) Fractionated co-culture 
extracts do not exhibit antimicrobial activity against Synechococcus. Fractions obtained from 
the HPLC separation of an organic extract of a co-culture supernatant after 35 days of 
incubation were spiked in axenic Synechococcus cultures, at a concentration of 4X. Fraction 
numbering is based on the HPLC elution time. ASW indicates the control culture in which only 
ASW was spiked-in. (B) Total extracts of Salinispora supernatants do not show antimicrobial 
activity against Synechococcus. Photographs of a representative plate from three biological 
replicates are shown. Indicated times (T) correspond to days of incubation. Arrows highlight 
inhibition zones. Discs were coated with either a 50X axenic Synechococcus culture organic 
extract (Ax), a 50X Salinispora-Synechococcus co-culture organic extract (Cc), 10 μg mL-1 




















































and processing of the co-culture extract, as well as allowed testing of the collective pool 
of secreted molecules. Unfortunately, the unfractionated extract similarly showed no 
antimicrobial activity against the phototroph (Fig. 18, B). 
While we were unable to link the killing phenotype observed in our co-culture with the 
cryptic compounds, we worked toward the elucidation of their chemical structures for 
further characterization. This required first the development of a purification method 
tailored for the molecules of interest, applicable to large volumes of culture supernatant. 
We successfully generated 4 L of co-culture supernatant, from which we isolated 
molecule 6 using a two-step HPLC protocol based on the polarity and light absorption of 
the analytes, as compound 6 had a characteristic UV-VIS absorption at 310 nm (Fig. 19).  
Despite multiple attempts, however, we obtained no informative signal from NMR 
analysis of the isolated cryptic molecule because of low titers of the compounds 
(Appendix 4), preventing so far the determination of its structure. 
 
 
Figure 19 | Isolation of the cryptic compound 6 from the co-culture extract. (A) The molecule 6 
can be purified by HPLC from the fraction obtained after a first time-based isolation step, using 
its absorbance at 310 nm. Graph shows HPLC chromatogram from DAD 310 nm. Red line 
indicates detector threshold for collection (500 mAU). (B) The resulting fraction (HPLC-purified 
extract) is a pure sample of 6, compared to the original co-culture extract (Total extract) and a 
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We show that S. tropica is able to inhibit the growth of both marine cyanobacteria and 
eukaryotic phototrophs by some yet unidentified mechanism (Fig. 11, B). This 
observation broadens the potential role and impact that members of the Salinispora 
genus have on marine microbial communities. Members of the three Salinispora species 
are widely-distributed bacteria found in all tropical and subtropical oceans 
(Bauermeister et al., 2018; Mincer et al., 2002). While mostly inhabiting marine 
sediments, bacteria from this genus have also been isolated from the microbiota of 
seaweeds, marine sponges and more recently corals (Asolkar et al., 2010; Jensen et al., 
2005; Ocampo-Alvarez et al., 2020). In marine sponges, it is suggested that they influence 
the sponge microbiota through the production of acyl homoserine lactone molecules and 
antibiotics (Bose et al., 2017; Singh et al., 2014). Similarly, different species of Salinispora 
were shown to possess distinct mechanisms to outcompete co-occurring marine 
heterotrophs in sediments, i.e. through the production of siderophores to deplete iron 
or antimicrobial molecules (Patin et al., 2017; Tuttle et al., 2019), although no 
antimicrobial compound has yet been identified for S. tropica (Patin et al., 2018). We 
herein provide the first evidence that Salinispora might not only directly influence 
heterotrophic communities, but also kill both prokaryotic and eukaryotic phytoplankton 
to which they are exposed, e.g. when these sediment out of the water column (Guidi et 
al., 2016), grow in sunlit coastal sediments (Patin et al., 2017) or are part of the same 
coral-associated microbiota (Ocampo-Alvarez et al., 2020). 
While we were successful in identifying and obtaining the molecular formulae of novel 
cryptic metabolites produced in response to phytoplanktonic photosynthate (Fig. 12, B; 
Fig. 17), we were unable to isolate and identify the compound responsible for the 
antimicrobial effect on the marine phototrophs by using traditional bioactivity-guided 
assays with crude or HPLC-fractionated co-culture extract (Fig. 18). This mechanism 
proved similarly elusive in previous studies, where S. tropica showed an antimicrobial 
activity on marine heterotrophs, but the molecule responsible was not identified (Patin 
et al., 2018; Patin et al., 2016). The parallelism between our observations and those 
described in the literature suggests that the active compound(s) may be the same. We 
reason that the compound’s instability, low titers and/or synergic effect of several 
molecules required for activity could explain the difficulty in identifying the antimicrobial 
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agent and may require constant production of the compound to result in cell death. For 
instance, the large number of structurally-related metabolites resulting from the 
chemical reaction of salinosporamide with various compounds (i.e. water, Tris) may 
support this hypothesis, as the antimicrobial molecule may be similarly unstable. The 
diversity of products arising from a single BGC may also be due to the promiscuity of the 
biosynthetic enzymes utilizing structurally related primary precursors. This results in a 
range of compounds, each produced at lower titers than a single natural product, and 
ultimately hamper the isolation of sufficient amounts of the compounds of interest. 
Similarly, the structure elucidation of the cryptic molecules has so far proven extremely 
challenging, as the quantities of compounds purified from 4-liter co-cultures were 
insufficient to generate informative signals by NMR. While solving the structures of other 
Salinispora molecules was typically made possible by the ease with which one can grow 
liters of axenic culture in rich broth (e.g. 20 L for salinosporamide; Feling et al., 2003), 
the cryptic metabolites reported here are only synthesised in response to a phototroph 
in a nutrient-limited media. Supporting the growth of marine phytoplankton in large 
cultures is arduous and it is hence remarkably difficult to obtain substantial volumes of 
Salinispora-phototroph co-cultures. The isolation method that we developed, based on 
the characteristic UV-VIS absorption of one of the compounds should, however, support 
future efforts made to purify larger amounts of the cryptic metabolites from scaled-up 
co-cultures and ultimately allow for their structure determination. 
In conclusion, we show that S. tropica can produce a broad-range antibiotic able to affect 
both unicellular prokaryotes and eukaryotes alike, such as the marine diatom and 
coccolithophore tested in our study. Such a broad-range antimicrobial could suggest a 
mode of action affecting a common target present in both types of cells such as the 
proteasome, a proteolytic complex present in the three domains of life (Becker & 
Darwin, 2017). Finally, our study pioneers the use of phototrophs as a promising strategy 
to trigger novel natural products from marine actinobacteria, as our metabolomics 
analysis identified cryptic secondary metabolites produced in response to co-inoculated 
phytoplankton. Future work is, however, required to elucidate the structure of the new 
molecules and because of their elusive nature, research efforts should also focus on 
identifying candidate pathways responsible for their production (e.g. pathways 
upregulated in presence of photosynthate).   
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C H A P T E R  3  |   
A N A L Y S I S  O F  S A L I N I S P O R A  T R O P I C A ’ S  P R O T E O M E  
R E V E A L S  A N  O R P H A N  N R P S  G E N E  C L U S T E R  E N C O D I N G  A  
P O T E N T I A L  P R O T E A S O M E  I N H I B I T O R   
 
INTRODUCTION 
Biosynthetic gene clusters (BGCs) are groups of co-localized genes encoding multi-
modular enzyme complexes responsible for the synthesis of most natural products. For 
instance, a non-ribosomal peptide synthetase (NRPS)-type cluster traditionally consists 
of catalytic units, each responsible for the incorporation of one non-proteinogenic 
amino-acid to a growing oligopeptide (Fig. 8; Scott & Piel, 2019; Walsh, 2008). These 
modules are themselves composed of core domains (e.g. adenylation (A), peptidyl 
carrier protein (PCP) or condensation domain (C)) that are required for the assembly of 
the natural product (Mootz et al., 2000). In addition to those pivotal biosynthetic 
enzymes, BGCs typically encode proteins involved in regulation and export, as well as 
self-resistance in case of an antimicrobial metabolite (Corre et al., 2008; Medema et al., 
2015; Tenconi & Rigali, 2018). The highly organized architecture of BGCs facilitates their 
identification and annotation by increasingly efficient bioinformatics pipelines (Blin et 
al., 2019; Medema et al., 2015; Mungan et al., 2020). Most of these biosynthetic loci that 
are reported bioinformatically have, however, yet to be assigned to their products and 
are named orphan BGCs. They are generally assumed to be either transcriptionally silent 
(i.e. poor or conditional level of expression or inactivation of their biosynthetic genes) or 
the molecules they produce are difficult to detect and isolate (i.e. compound instability, 
limited sensitivity of detection methods or absence of bioactivity to screen for) (Rutledge 
& Challis, 2015).  
These issues are well exemplified in the marine actinomycete Salinispora, a remarkable 
producer of new secondary metabolites with drug-like properties (Asolkar et al., 2010; 
Gulder & Moore, 2010; Janso et al., 2014). Previous studies have shown that 10% of the 
type strain S. tropica CNB-440T genome is dedicated to natural product biosynthesis with 
the identification of twenty putative BGCs, of which eleven are still orphan (Table 2; Penn 
et al., 2009; Udwary et al., 2007). In Chapter 2, we have used co-inoculation of S. tropica 
with phytoplankton as a means to activate those orphan clusters that are silent. We have 
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demonstrated that co-cultures not only triggered the production of cryptic compounds 
in S. tropica, but also revealed an antimicrobial activity exhibited by S. tropica against the 
phototrophs that we could not link to any molecule. While our work and that of others 
have focused on activating silent BGCs, little has been done to characterize those orphan 
BGCs as either being silent or producing cryptic molecules, and to propose candidate 
BGCs that could be linked to the bioactivity of undetectable metabolites. The only 
available study of the type in Salinispora, to date, is based on a comparative 
transcriptomics analysis of various Salinispora species that recently allowed the 
discovery of the compound salinipostin, as well as the report of seven transcriptionally 
silent BGCs (Table 3; Amos et al., 2017). Meanwhile, combining metabolomics with 
proteomics has proven successful in linking novel secondary metabolites to active 
orphan BGCs in several Streptomyces species, but has not yet been applied to the genus 
Salinispora (Bumpus et al., 2009; Chen et al., 2013; Gubbens et al., 2014; Owens et al., 
2014; Schley et al., 2006).  
 
Table 3 | Previously reported activity of orphan biosynthetic gene clusters in S. tropica.  
 
* Based on the comparative transcriptomics analysis done by Amos et al. (2017), in S. tropica 
CNB-440 grown axenically in A1 medium in exponential phase. 
 
Here, we report the first available proteomics dataset in S. tropica CNB-440 that we 
explored to identify candidate BGCs that could be linked to the antimicrobial activity 
exhibited by Salinispora in co-culture and/or responsible for the biosynthesis of the 
cryptic metabolites observed in our metabolomics study. Using comparative proteomics 
BGC name Biosynthetic class Genetic location (strop_) Size (kb) Found transcriptionally silent*
pks1 polyketide RS02980-RS03095 30.9 Yes
nrps1 non-ribosomal peptide RS03375-RS03535 37.5 Yes
amc carbohydrate RS11765-RS11795 6.6 Yes
bac1 ribosomal peptide RS11800-RS12275 19.2 No
pks3 polyketide RS12510-RS12630 23.3 No
sid2 non-ribosomal peptide RS13260-RS13385 40.7 Yes
sid3 non-ribosomal peptide RS13985-RS14120 29.2 Yes
sid4 non-ribosomal peptide RS14125-RS14260 40.8 Yes
bac2 ribosomal peptide RS14265-RS15290 19.0 No
pks4 polyketide RS21120-RS21540 10.0 No
nrps2 non-ribosomal peptide RS22250-RS22350 34.7 Yes
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analysis, we show that the orphan BGC nrps1 is highly active and a promising candidate 
for the production of a potential antimicrobial proteasome inhibitor. 
 
MATERIAL AND METHODS 
1. Culture conditions 
1.1. Strains and growth media 
Axenic marine phototroph Synechococcus sp. WH7803 was routinely grown in Artificial 
Seawater (ASW, Wilson et al., 1996). Cultures were set-up in Falcon 25 cm² rectangular 
culture flasks with vented caps containing 20 mL of media and incubated at a constant 
light intensity of 10 μmol photons m-2 s-1, at 22 °C with orbital shaking (140 rpm). The 
type strain Salinispora tropica CNB-440T was grown in marine broth (MB, Difco), and 
incubated at 30 °C with orbital shaking (220 rpm). 
 
1.2. Incubation setup 
To compare the proteome of Salinispora incubated in MB, ASW and in the presence of 
photosynthate, cells were washed and resuspended in either MB, ASW or a conditioned 
Synechococcus supernatant (SUPSYN), as appropriate. Cells were first grown to late 
exponential phase in 10 mL of MB before washing them three times with MB, ASW or 
SUPSYN, and finally resuspending the washed cell pellet in 10 mL of the same media. 
Washed Salinispora cells were inoculated in 10 mL of fresh MB, ASW or SUPSYN media 
to a concentration of 25% (v/v), and cultures were incubated for 5 days at 22 °C with 
shaking (140 rpm) and a light intensity of 10 μmol photons m-2 s-1.  
To obtain the conditioned supernatant, Synechococcus cultures were incubated 
axenically for 35 days as described above (‘Strains and growth media’ section) before 
centrifugation (4000 x g for 10 minutes at room temperature) and further filtration 
through 0.22 µm pore size filters to remove cells and particulate organic matter.  
 
2. Proteomic analysis 
2.1. Preparation of cellular proteome samples 
Cultures were set up as described above and incubated for 5 days after which cells were 
collected by centrifuging 10 mL of culture at 4,000 x g for 10 minutes at 4 °C. Cell pellets 
were placed on dry ice before storing at -20 °C until further processing. The cell pellets 
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were resuspended in 200 μL 1x NuPAGE lithium dodecyl sulfate (LDS) sample buffer 
(ThermoFischer Scientific), supplemented with 1% ß-mercaptoethanol. Cell pellets were 
lysed by bead beating (2x45 sec and 1x30 sec at 6.0 m/s) and sonication (5 min), followed 
by three successive 5-min incubations at 95 °C with short vortex steps in between. Cell 
lysates containing all proteins were loaded on an SDS-PAGE precast Tris-Bis NuPAGE gel 
(Invitrogen), using MOPS solution (Invitrogen) as the running buffer. Protein migration 
in the SDS-PAGE gel was performed for 5 min at 200 V, to allow removal of contaminants 
and purification of the polypeptides. The resulting gel was stained using SimplyBlue 
SafeStain (Invitrogen) to visualize the cellular proteome. The gel bands containing the 
cellular proteome were excised and stored at -20 °C until further processing.  
 
2.2. Trypsin in-gel digestion and nano LC-MS/MS analysis 
Polyacrylamide gel bands were destained and standard in-gel reduction and alkylation 
were performed using dithiothreitol and iodoacetamide, respectively; after which 
proteins were in-gel digested overnight with 2.5 ng μL-1 trypsin (Christie-Oleza & 
Armengaud, 2010). The resulting peptide mixture was extracted by sonication of the gel 
slices in a solution of 5% formic acid in 25% acetonitrile, and finally concentrated at 40 
°C in a speed-vac. For mass spectrometric analyses, peptides were resuspended in a 
solution of 0.05% trifluoroacetic acid in 2.5% acetonitrile prior to filtering using a 0.22 
µm cellulose acetate spin column. Samples were analyzed by nanoLC-ESI-MS/MS with an 
Ultimate 3000 LC system (Dionex-LC Packings) coupled to an Orbitrap Fusion mass 
spectrometer (Thermo Scientific) using a 60 minutes LC separation on a 25 cm column 
and settings as previously specified (Christie-Oleza et al., 2015). 
 
2.3. Proteomic data analysis  
Raw mass spectral files were processed for protein identification and quantification using 
the software MaxQuant (version 1.5.5.1; Cox & Mann, 2008) and the UniProt database 
of S. tropica CNB-440 (UP000000235). Quantification and normalization of spectral 
counts was done using the Label-Free Quantification (LFQ) method (Cox et al., 2014). 
Samples were matched between runs for peptide identification and other parameters 
were set by default. Data processing was completed using the software Perseus (version 
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1.5.5.3). Proteins were filtered by removing decoy and contaminants and were 
considered valid when present in at least two replicates for one condition. The relative 
abundance of each protein was calculated using protein intensities transformed to a 
logarithmic scale with base 2 and normalized to protein size. Variations in protein 
expression between the SUPSYN and MB conditions were assessed with a two-sample T-
test, with a false discovery rate (FDR) q-value below 0.05 and a log(2) fold change above 
2. When comparing the MB and ASW conditions against SUPSYN, variations in protein 
expression were analyzed by one-way ANOVA (with a FDR q-value below 0.05 and a 
log(2) fold change above 2) followed by Tukey’s HSD post hoc test when ANOVA 
indicated significant differences. 
 
Table 4 | Summary of the proteomic dataset. 
 
 
a Table shows the cumulated relative abundance of the detected proteins linked to biosynthetic 
gene clusters, indicated as mean ± standard deviation of three biological replicates. Tukey HSD 
test, ** significant at q-value < 0.01; *** significant at q-value < 0.001.  
 
RESULTS 
Overview of the Salinispora tropica proteome dataset 
Having detected novel secondary metabolites produced by S. tropica in response to 
phototroph-released photosynthate, we set out to investigate how it affected the 
induction of its BGCs. To this end, we analyzed and compared the proteomes of S. tropica 
grown in presence of the phytoplankton photosynthate – i.e. in a conditioned 
Synechococcus supernatant (SUPSYN) where the cryptic molecules are produced – and 
in nutrient rich broth – i.e. marine broth (MB) where the cryptic molecules are not 
detected. Considering that the medium SUPSYN is effectively artificial seawater with 
some phototroph-released nutrients, we also incubated S. tropica in fresh artificial 
seawater (ASW) as a control. The rationale behind using the SUPSYN medium rather than  
Strain studied
(No. of proteins)
Growth medium Detected proteins
(% of total proteins)
Detected proteins related to BGCs







1,869 (41.3) 179 (9.6) 9.6 ± 0.9
Artificial Seawater
(ASW)
1,797 (39.7) 172 (9.6) 11.4 ± 0.4
Phototroph supernatant





Figure 20 | Photosynthate allows expression of orphan biosynthetic gene clusters in S. tropica. 
Characterized (orange) and orphan BGCs (green) in S. tropica CNB-440 detected by high-
throughput proteomics when grown with photosynthate (SUPSYN) for 5 days. Genes are colored 
according to the relative abundance of their corresponding proteins. Those that were not detected 
are represented in black.  























co-inoculating S. tropica with Synechococcus was two-fold. First, it had the advantage to 
avoid Synechococcus proteins that may interfere with the correct detection of 
Salinispora proteins. Second, we reasoned that it would reduce potential variations in 
protein expression caused by Synechococcus-Salinispora cell to cell interactions and/or 
the limitation in carbon availability that would occur early in the co-culture in ASW.  
Overall, the datasets obtained contain close to 1,900 proteins, representing about 40 % 
of the total expected proteome of S. tropica (Table 4). We found that 10 % of those 
detected proteins could be linked to BGCs (Table 4), a figure consistent with the 
estimated percentage of the S. tropica genome to be devoted to natural product 
assembly (Udwary et al., 2007). Interestingly, while the actual numbers of BGC-related 
proteins were similar in all three conditions tested, we found that their cumulative 
abundances accounted for a significantly higher proportion of the proteomes when cells 
were grown in presence of the phytoplankton’s photosynthate compared to both MB 
and ASW (Table 4). As we believed this observation suggests that phototrophic cells 
prompt an increase of S. tropica secondary metabolism, we were interested in 
identifying which BGCs were expressed and influenced by photosynthate. 
 
Photosynthate allows the expression of orphan gene clusters in S. tropica 
We were able to detect proteins encoded by almost all of S. tropica BGCs regardless of 
the incubation medium, including 10 of its 11 orphans BGCs (Fig. 20). For instance, the 
already characterized BGCs lom and sal were abundantly detected with 81% (47/58) and 
77% (23/30) of their encoded proteins detected, respectively, some representing high 
relative abundances within the proteome (Fig. 20). The BGC lom is linked to the cytotoxic 
glycoside lomaiviticin molecule (Kersten et al., 2013). However, this metabolite 
previously showed no antimicrobial activity on co-cultured heterotrophic organisms 
(Patin et al., 2018) and, hence, it is unlikely to cause the antimicrobial phenotype 
observed on the phototrophs in this study. The high abundance of the sal cluster 
producing the salinosporamide compound is expected given the high detection of this 
metabolite by LC-MS (see Chapter 2). 
Among the orphan BGCs, of particular interest were pks3 and nrps1, for which we 
detected 72% (18/25) and 42% (14/33) of their encoded proteins, respectively (Fig. 20). 
Moreover, the pks3 BGC was noticeably highly detected as seven of its detected proteins 
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showed a relative abundance above 0.1% (Fig. 20). While it has been previously 
suggested that pks3 may produce a spore pigment polyketide, very little experimental 
evidence is available in the literature, and the product of pks3 had not been identified 
(Kersten et al., 2013). On the other hand, the non-ribosomal peptide synthetase (NRPS) 
gene cluster nrps1, which was previously shown to be silent at the transcriptional level 
(Table 3; Amos et al., 2017), surprisingly appeared to be highly active in our experimental 
setup. We were able to detect three of the cluster core biosynthetic proteins, namely a 
non-ribosomal peptide synthetase (A4X2Q0), an adenylation domain-containing protein 
(A4X2R4) and a condensation domain-containing protein (A4X2R5), with a relative 
abundance of 0.004%, 0.004% and 0.001%, respectively (Table 5). This orphan BGC has 
only been predicted to produce a non-ribosomal dipeptide (Penn et al., 2009).  
Intriguingly, the most abundant protein detected from nrps1 was an ATP-dependent Clp  
Table 5 | Detected proteins from the nrps1 orphan BGC in S. tropica grown with photosynthate. 
 
a Core biosynthetic enzyme. 
b Protein potentially involved in self-resistance to a proteasome inhibitor. 
Protein ID Homologue (% identity/% similarity)Organism [Protein ID] Putative function
Relative abundance
(%; n = 3)
A4X2P5
ridA (33/54)
Bacillus subtilis [P37552.3] 2-iminobutanoate/2-iminopropanoate deaminase 0.014
A4X2P8
MFS transporter (28/41)












Mycrobacterium leprae [P73574.1] Acyl-CoA dehydrogenase 0.003
A4X2R1
YdiO (28/42)
Escherichia coli K-12 [p0A9U8.1] Acyl-CoA dehydrogenase 0.002
A4X2R4
ProA (gramicidin S synthase) (32/47)
Brevibacillus brevis [P0C064.2] Adenylation domain
a 0.004
A4X2R5






Nitratiruptor sp. [A6Q3P9.1] Argininosuccinate synthase 0.001
A4X2R8
Fmt (32/48)
Stenotrophomonas maltophilia [B2FIR3.1] Methionyl-tRNA formyltransferase 0.004
A4X2S2
clpP (69/85)




Methanocaldococcus jannaschii [Q57604.1] Potassium channel protein 0.002
A4X2S5
korB (65/77)
Mycobacterium tuberculosis [O53181.1] 2-oxoglutarate oxidorectudase subunit beta 0.006
A4X2S6
korA (66/78)
Mycobacterium tuberculosis [O53182.3] 2-oxoglutarate oxidoreductase subunit alpha 0.004
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protease subunit (A4X2S2), with a relative abundance of 0.121% (Table 5), a protein that 
may be involved in conferring resistance to a BGC-encoded antimicrobial compound 
(Kirstein et al., 2009), as further discussed below in this Chapter.  
 
Photosynthate increases the expression of the nrps1 orphan gene cluster 
Although all BGCs appeared to be similarly active between conditions with regards to the 
detection of their proteins (i.e. the same proteins were generally present in the different 
proteomes, rather than being conditional to one growth medium), a thorough 
comparative analysis of their expression levels revealed that phototroph-released 
nutrients could specifically trigger several proteins within a BGC (Fig. 21). For instance, 
the orphan pks3 BGC showed an up-regulation of the production of pivotal enzymes for 
polyketide biosynthesis when cells were grown in the SUPSYN medium compared to MB. 
Namely, an acyl-CoA ligase (A4X7T8), a 3-ketoacyl-ACP synthase (A4X7U0) and a long-
chain fatty acid-CoA ligase (A4X7U3) were up-regulated 3.1, 2.6 and 4.1-fold, respectively 
(Fig. 21, A). These variations in protein detection could not, however, be confidently 
attributed solely to the presence of photosynthate because they were also observed at 
similar levels between the MB and ASW conditions. This could indicate that the orphan 
pks3 cluster’s expression is regulated by nutrient availability as it is less active in a 
nutrient-rich broth like MB.  
On the other hand, the activity of the BGC nrps1 was more clearly influenced by 
photosynthate as 28% (4/14) of its detected proteins were significantly up-regulated in 
the SUPSYN medium versus MB (Fig. 21, B). They included three core biosynthetic 
enzymes, namely a non-ribosomal peptide synthetase (12.5-fold change; A4X2Q0), a 
ketoreductase domain-containing protein (1.6-fold change; A4X2Q2) and an adenylation 
domain-containing protein (3.4-fold change; A4X2R4). Furthermore, we were able to 
confirm that photosynthate specifically triggered an increase in the expression of at least 
three of them (i.e. A4X2Q0, A4X2Q2 and A4X2R0), as they exhibited a significant up-
regulation in SUPSYN compared to the two other media, but abundances alike between 
ASW and MB (Fig. 21, C). For instance, the non-ribosomal peptide synthetase A4X2Q0 
was up-regulated 5.5 and 12.5-fold in presence of the phytoplankton’s photosynthate 
versus in ASW or MB, respectively, while showing comparable activity in the two latter 




We here provide the first cellular proteome dataset for S. tropica CNB-440. Exploring its 
proteome exposed to photosynthate, we detected proteins encoded by almost all its 
BGCs, including most of its orphan BGCs (Fig. 20). This strengthens S. tropica potential 
 
Figure 21 | Photosynthate increases the expression of the orphan nrps1 BGC in S. tropica. 
Photosynthate and other nutrients influence several proteins from the orphan BGCs pks3 (A) 
and nrps1 (B), in comparison with cells grown in MB. Up- (red) and down-regulated (blue) 
proteins in the presence of the photosynthate (SUPSYN) are shown. Statistically significant fold 
changes are indicated by an asterisk (T-test, significant at q-value < 0.05). Enzymes further 
analyzed for a post hoc test are indicated by a double asterisk. (C) Photosynthate specifically 
triggers an up-regulation of several proteins from the nrps1 BGC. Up-regulated proteins in the 
presence of photosynthate compared to ASW (green) and MB (red) are shown. These proteins 
showed no significant difference between the MB and ASW conditions. Tukey HSD test, * 
significant at q-value < 0.05; ** significant at q-value < 0.01; *** significant at q-value < 0.001.  



















































































































































































for novel natural product discovery, as most of these orphan BGCs may be poorly 
expressed or producing molecules difficult to detect, rather than to be silent or 
inactivated. Notably, while detection and relative abundance of proteins for the lom 
cluster strongly suggest production of lomaiviticin, we were not able to detect it in our 
experimental setup. In this regard, the lom BGC provides an interesting example of a 
small compound for which both protein and transcription levels indicate its biosynthesis, 
but analytical chemistry fails to allow its detection. This observation also challenges the 
assumption that most of the BGCs corresponding to un-detected molecules are silent, 
and highlight the necessity to improve isolation and detection of natural products, as it 
has previously been discussed (Amos et al., 2017). In comparison, the sal BGC, producing 
the salinosporamide compound, was one of the most highly expressed BGC as several of 
its proteins were detected with high relative abundance. This finding is in agreement 
with previous studies that have shown by transcriptomics that the BGC sal is highly and 
constitutively expressed when grown in nutrient rich A1 medium (Amos et al., 2017). 
Also, the high expression of this BGC correlated with a noticeable detection of 
salinosporamide derivatives by LC-MS. Therefore, the abundant detection of several 
orphans BGC proteins, including those from pks3 and nrps1 BGCs, may be interesting 
candidates responsible for the biosynthesis of the cryptic metabolites detected by LC-
MS we reported in Chapter 2. 
The proteins detected from the BGC nrps1 are essential enzymes involved in non-
ribosomal peptide biosynthesis, i.e. A4X2Q0, a non-ribosomal peptide synthetase (NRPS) 
made of a C-A-PCP domain; A4X2Q2, a ketoreductase domain-containing protein; 
A4X2R4, an adenylation domain-containing protein; and A4X2R5, a condensation 
domain-containing protein made of C-PCP-TE domain. The detection of these proteins 
therefore strongly suggests the actual synthesis of the non-ribosomal peptide and could 
well be the cryptic metabolites 4, 6 and 7 detected by LC-MS (see Fig. 12, B from Chapter 
2). The molecules indeed include four nitrogen atoms in their predicted molecular 
formulae and four identified A-domains, which are responsible for the selection and 
activation of the amino-acids monomers incorporated into the non-ribosomal peptide, 
are encoded in the nrps1 BGC. Interestingly, while the substrate specificity of A4X2Q0’s 
A-domain is alanine, the one of A4X2R4 and the two others could not be predicted. We 
also show that the proteins encoded by the nrps1 BGC were more abundantly detected 
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with photosynthate (Fig. 21), which is consistent with our previous observation that the 
detection of the molecules is conditional to the presence of phytoplankton or their 
photosynthate. This correlation supports the orphan nrps1 as a promising candidate for 
the production of the cryptic compounds and, potentially, the antimicrobial activity 
observed on co-cultured phototrophs. 
Intriguingly, we detected from this same BGC a highly abundant ATP-dependent Clp 
protease proteolytic subunit (ClpP, A4X2S2) that may be providing S. tropica with self-
resistance against the nrps1 peptides. Virtually all organisms across the tree of life have 
a system for targeted proteolysis for protein turnover, with most bacteria, mitochondria 
and chloroplasts relying on a ClpP-type proteasome while eukaryotes, archaea and some 
actinobacteria typically possess the homologous 20S proteasome structure (Becker & 
Darwin, 2017; Snoberger et al., 2017). The ClpP proteasome is known to be the target 
for certain antibiotics, including the novel acyldepsipeptide (ADEP) class (Kirstein et al., 
2009), and it is common to find alternative ClpP proteasomes encoded nearby the 
antibiotic-producing BGC to confer resistance to the host cell (Thomy et al., 2019). In a 
similar fashion, salinosporamide A is a 20S proteasome inhibitor, to which S. tropica is 
resistant because of an extra copy of the proteasome beta subunit gene within the 
salinosporamide-producing cluster (Kale et al., 2011). We can thus reasonably infer from 
the presence of clpP in the nrps1 BGC that it is likely to produce an antibiotic targeting 
the ClpP proteasome, a class of antimicrobial compounds that has recently gained 
considerable attention as an attractive option to tackle multidrug resistant pathogens 
(Culp & Wright, 2017; Momose & Kawada, 2016; Moreno-Cinos et al., 2019). We here 
provide the first proteomic evidence that S. tropica’s nrps1 is active and may produce a 
promising antimicrobial compound acting as a ClpP proteasome inhibitor. The synthesis 
of such an antibiotic would explain the antimicrobial effect of S. tropica on all marine 
phototrophs tested in our study (see Chapter 2) as they all rely on the ClpP proteolytic 
machinery (Andersson et al., 2009; Jones et al., 2013; Zhao et al., 2018).  
We here provide a valuable insight into the biosynthetic potential of S. tropica with our 
proteomic dataset, as it revealed the expression of several orphan BGCs, including the 
nrps1 cluster that was previously reported to be silent (Amos et al., 2017). We show that 
a protein-based study can help in the identification of candidate BGCs for the discovery 
of novel natural products. Our comparative proteomic analysis demonstrated that the 
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photosynthate released by primary producers influences the biosynthetic capacities of 
S. tropica, activating the expression of the orphan BGCs nrps1, a promising candidate for 
antibiotic production that could encode the detected cryptic molecules. Additional 
evidence, such as genetic inactivation of the nrps1 BGC, will confirm this mechanism. For 
this, future work will involve the development of a genome engineering method in S. 
tropica that would allow the fast deletion of candidate BGCs, and support the bioactivity-
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INTRODUCTION 
The marine actinomycete Salinispora is a promising genus for the discovery of novel 
natural products, with anti-cancer and antibiotics compounds having been isolated from 
its three species (Asolkar et al., 2009; Feling et al., 2003; Janso et al., 2014; Nett & Moore, 
2009). Although many new molecules have been sourced from this genus already, its full 
potential for secondary metabolite production remains to be exploited. Sequencing of 
the type strain S. tropica CNB-440T, for instance, lead to the identification of twenty 
biosynthetic gene clusters (BGCs), of which eleven are still orphan (Penn et al., 2009; 
Udwary et al., 2007). Recent studies also showed that some strains exhibited 
antimicrobial activity in co-cultures against marine heterotrophs but traditional 
analytical chemistry methods failed to enable the identification of the molecule 
responsible (Patin et al., 2018; Patin et al., 2016). We have similarly reported in Chapter 
2 that S. tropica inhibits phytoplankton’s growth and that it produces cryptic compounds 
in response to the co-culture. Additionally, analysis of S. tropica’s proteome presented 
in Chapter 3 suggests that several of its orphan BGCs might well be active but their 
products have yet to be characterized (e.g. pks3, nrps1 and nrps2). The link between 
these different observations remains to be established via the assignment of the 
antimicrobial activity observed in co-culture and/or the production of the cryptic 
compounds to one of S. tropica BGCs. 
This strategy would rely on the ability to inactivate several BGCs in S. tropica using 
genome editing. Instead of individually deleting each BGC, however, one could inactivate 
groups of BGCs by targeting phosphopantetheinyl transferases (PPTases), a family of 
enzymes essential for the biosynthesis of secondary metabolites (Beld et al., 2014). All 
polyketide synthase (PKS) and non-ribosomal peptide synthetase (NRPS) systems, for 
instance, require the activity of PPTases, dedicated or not, to produce their natural 
products. Briefly, NRPS- and PKS-based biosynthesis relies on modules, where one 
module is responsible for the iterative addition of one building block (i.e. amino-acid and 
acyl-coenzyme A, respectively) to the nascent molecule. In NRPS systems, each module 
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comprises several protein domains, typically an adenylation, peptidyl carrier protein 
(PCP), condensation and thioesterase domains (Fig. 8; Mootz et al., 2000). Briefly, an 
amino-acid selected and activated by the adenylation domain is loaded onto the PCP 
domain. The condensation domain catalyzes the formation of a peptide bond between 
the PCP-bound amino-acid and the growing peptide chain of the upstream module. 
Finally, the thioesterase domain releases the mature oligopeptide from the NPRS 
assembly line (Fischbach & Walsh, 2006; Süssmuth & Mainz, 2017). This process is, 
however, possible only after a PPTase transfers a phosphopantetheine (PPant) moiety to 
the conserved serine of an inactive apo-PCP domain, resulting in its active holo-form 
(Beld et al., 2014; Fig. 22). The PPant then acts as a flexible ‘arm’ onto which the 
intermediates of the assembly lines are transiently held, allowing their shuttling to the 
neighbouring protein domains, making the molecule biosynthesis possible (Lambalot et 
al., 1996). PPTases are also known to possess broad specificity, with one PPTase often 
being able to activate a specific set of several BGCs, therefore representing a promising 
target to inactivate multiple BGCs by single gene deletion (Beld et al., 2014; Zhang et al., 
2017).   
 
 
Figure 22 | PPTases are essential for the biosynthesis of all PKSs and NRPSs natural products. 
Scheme of PCP activation by a PPTase. PPTases modify PCP domains post-translationally by 
adding a PPant moiety to the conserved serine of inactive apo-PCPs, resulting in their active 
form holo-PCPs, allowing the loading and shuttling of intermediates which is pivotal to non-
ribosomal peptide and polyketide natural product biosynthesis. 
 
Gene integration and deletion in the genus Salinispora has previously been done to study 
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vectors and PCR-targeted mutagenesis (Bucarey et al., 2012; Eustáquio et al., 2010). 
These techniques could be used to generate PPTase mutants, however, they present one 
or several of the following drawbacks: (a) integration of a selectable marker limiting the 
number of genomic modifications possible in a cell, (b) lack of stability of the single cross-
over and (c) relatively time-consuming protocols requiring several steps to obtain 
marker-free mutants (Datsenko & Wanner, 2000; Gust et al., 2003; Kieser et al., 2000). 
While the CRISPR/Cas9 technology allows rapid generation of marker-less double cross-
over mutants and has been applied successfully in soil actinobacteria, it has yet to be 
used in Salinispora (Alberti et al., 2019; Jinek et al., 2012).  
Here, we implemented for the first time the CRISPR/Cas9 technology to perform whole-
BGC and single-gene PPTase deletion in the genus Salinispora. We use a combination of 
metabolomics and proteomics to characterize a mutant strain deficient in the PPTase 
2496. Our preliminary data suggests that PPTases in S. tropica are functionally redundant 
and that improving the CRISPR/Cas9 efficiency could lead to its successful use for the 
global inactivation of BGCs in the genus Salinispora. 
 
Table 6 | Bacterial strains and plasmids used in this study. 
 
Strain Genotype Reference or source
E. coli DH5!
F– endA1 glnV44 thi-





New England Biolab 
(NEB)
E. coli ET12567-∆DAP
dam-13::Tn9, dcm-6, hsdM, hsdS, ﻿ΔdapA::(erm-pir); contains         
pUZ8002
Allard et al., 2015
S. tropica CNB-440 Wild-type
Maldonado et al., 2005;
DSM No.: 44818
S. tropica ∆2496 Derivative of S. tropica CNB-440, ∆strop_2496 (PPTase 2496) This study
S. tropica ∆nrps2 Derivative of S. tropica CNB-440, ∆strop_4429-4409 (BGC nrps2) This study
Plasmid Description Reference or source
pCRISPomyces-2
Codon-optimized cas9 from Streptococcus pyogenes; lacZ
flanked by BbsI sites for Golden Gate cloning of crRNA; XbaI site
for addition of homology arms; temperature-sensitive pSG5
origin and apramycin resistance marker
Cobb et al., 2015
pCRISPomyces-0685 Derivative of pCRISPomyces-2, targets PPTase 0685 This study
pCRISPomyces-0777 Derivative of pCRISPomyces-2, targets PPTase 0777 This study
pCRISPomyces-2496 Derivative of pCRISPomyces-2, targets PPTase 2496 This study
pCRISPomyces-2822 Derivative of pCRISPomyces-2, targets PPTase 2822 This study
pCRISPomyces-nrps1 Derivative of pCRISPomyces-2, targets the BGC nrps1 This study
pCRISPomyces-nrps2 Derivative of pCRISPomyces-2, targets the BGC nrps2 This study
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MATERIAL AND METHODS 
 1. Strains and growth conditions 
Retargeting of the pCRISPomyces-2 vector was performed using commercial chemically 
competent E. coli DH5α cells (NEB). Conjugation of retargeted pCRISPomyces-2 was done 
using E. coli ET12567-DDAP, a diaminopimelic acid (DAP)-auxotroph and methylation-
deficient donor strain containing the RP4 conjugation machinery in the helper plasmid 
pUZ8002 (Table 6; Allard et al., 2015). The strain was kindly provided by the Roy 
laboratory (Canada). E. coli cells were routinely cultured in Luria-Bertani (LB) broth 
supplemented with 50 μg mL-1 kanamycin, 25 μg mL-1 chloramphenicol, 50 μg mL-1 
apramycin and 60 μg mL-1 DAP, when required. 
Salinispora tropica CNB-440 was routinely grown in marine broth (Difco) and incubated 
at 30 °C with shaking (220 rpm). Marine broth was supplemented with 100 μg mL-1 
apramycin, when required. Setup of co-cultures with Synechococcus WH7803 and 
description of SUPSYN is described in the Material and Methods section of Chapter 2. 
 
2. Construction of S. tropica mutants 
2.1.  Retargeting of pCRISPomyces-2 
In order to knock-out the selected PPTases, we retargeted the pCRISPomyces-2 vector, 
a CRISPR/Cas9-based system optimized for genome editing of Streptomyces, following 
the author guideline provided in the supporting information (Cobb et al., 2015). Briefly, 
protospacer design was based on S. tropica CNB-440 genome (NC_009380), using the CRISPY-
webtool (crispy.secondarymetabolites.org; Blin et al., 2016). Targets were 
STROP_RS03465 (strop_0685), STROP_RS03935 (strop_0777), STROP_RS12565 
(strop_2496), STROP_RS14165 (strop_2822), STROP_RS03535 and STROP_RS03375 
to delete the nrps1 gene cluster, as well as STROP_RS22350 and STROP_22250 to delete 
the nrps2 gene cluster. Protospacers for each target were selected to be: (a) 20-bp for 
the full sgRNA, (b) with the 3’ protospacer adjacent motif (PAM) NGG, (c) on the non-
coding strand, (d) unique in the genome even with 1-bp mismatch, and (e) located 
centrally within the target, when possible.  
For PPTase deletion, selected protospacers were synthesized as two 24-bp 
oligonucleotides that were the reverse complement of each other, such that the 
annealed product resulted in double-stranded protospacers with BbsI-compatible 
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overhangs (Appendix 5). For BGC deletion, two guide RNA cassettes were required and 
protospacers were synthesized as a synthetic construct (Appendix 5). Protospacers and 
synthetic constructs were cloned into pCRISPomyces-2 using Golden Gate Assembly. To 
allow precise editing via homologous recombination, two ~ 1-kb arms corresponding to 
the sequences flanking the Cas9-induced deletion were cloned into the retargeted 
pCRISPomyces-2 plasmids using Gibson Assembly (Appendix 5). 
 
2.2. Plasmid conjugation 
For cell mating, 3 mL of donor E. coli ET12567-DDAP cells were grown overnight in LB 
medium. The overnight cultures were back-diluted into 10 mL of LB medium and grown 
to an optical density of 0.4-0.6. Medium used up to this stage was supplemented with 
the appropriate antibiotics and DAP. Donor cells were then washed three times with 
fresh LB medium to remove antibiotics, and then re-suspended in 500 μL of LB medium 
without antibiotics. Recipients for conjugation were spores of S. tropica CNB-440 
collected from cells grown onto one A1- and one MB-agar plate for 30 days at 30 °C. 
Spores were isolated from mycelium in suspension by filtering through a sterile 10-mL 
syringe with added cotton wool. Spores were pelleted and resuspended into 500 μL of 
A1 medium.  
Donor and recipient cells were mixed, pelleted, resuspended in about 50 μL of the 
remaining media and finally aliquoted onto solid MB media as 10 μL spots. Cells were 
incubated for 16-20 hours at 30 °C to allow mating. To select for successful plasmid 
conjugations, cells were re-suspended from the plates into 100 μL of MB medium, plated 
onto solid MB media supplemented with 100 μg/mL apramycin, and incubated at 30 °C 
for about 12 days. 
 
2.3. Knock-out verification 
Exconjugants were first grown in MB medium supplemented with apramycin to confirm 
resistance and plasmid acquisition. Genomic DNA was extracted from the resulting 
cultures using a DNeasy plant mini kit (Qiagen), modified with an additional bead beating 
step (2x45 sec and 1x30 sec at 6.0 m/s). Extracted DNA was used as template to check 
the deletion of the PPTases and BGCs by PCR using primers listed in Appendix 6. PCR-
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amplified fragments containing the deleted junction were also verified using Sanger 
sequencing. 
 
3. Mutant strain characterization 
3.1.  Cell counting via flow cytometry 
Synechococcus cell abundance in co-culture was monitored using its autofluorescence by 
flow cytometry using a LSR Fortessa Flow Cytometer (BD) instrument, and the BD 
FACSDiva acquisition software (BD). Cells were detected and gated using ex. 488 nm – 
em. 710/50 nm at voltage 370 V, and ex. 640 nm – em. filter 670/14 nm at voltage 480 
V. To remove any Salinispora cell aggregates that would block the flow cell, samples were 
pre-filtered through a sterile mesh with pore size of 35 μm (Corning) prior to analysis. 
 
3.2. LC-MS analysis 
Details of the preparation of metabolomics samples can be found in the Material and 
Methods of Chapter 2 (section 2). Briefly, the co-culture supernatants were analyzed 
after 35 days by non-targeted metabolomic using supernatant crude extracts. For this, 
cells from 10 mL of cultures were removed by centrifugation (4,000 x g for 15 minutes) 
followed by a filtering step using 0.22 μm vacuum filter bottle system (Corning). Pre-
purification of the organic compounds from the supernatants was carried out by solid 
phase extraction using C18-silica, as described in Chapter 2 (section 2.1.). The obtained 
extract was dried under reduced pressure at 40 °C (in a speed-vac) and resuspended in 
1 mL of 50:50 HPLC-grade methanol/water solution. All samples were stored in snap-seal 
amber glass vials (Thames Restek) and kept at -20 °C until analysis. 
Metabolites were analyzed by reversed-phase liquid chromatography. A Dionex UltiMate 
3000 HPLC (ThermoScientific) coupled with an amaZon SL Ion Trap MS (Bruker) was used. 
A Zorbax Eclipse Plus C18 column with dimensions 4.6 mm x 150 mm, 5 μm particle size 
(Agilent Technologies) was employed for metabolite separation with the same linear 
gradient specified in Chapter 2 (section 2.2.). The mass spectrometer (MS) was operated 
in positive ion mode with a 100-1000 m/z scan range. The injected volume was 10 μL at 
a temperature of 25 °C. Data was processed with the Bruker Compass DataAnalysis 
software version 4.2 (Bruker). 
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4. Proteomic analysis 
Details of the preparation of cellular proteome samples can be found in the Material and 
Methods of Chapter 3 (section 2.1.). Briefly, cultures were set up as previously described 
and incubated for 5 days in MB. Protein extracts were purified from contaminants via 
SDS-PAGE gel migration. The gel bands containing the cellular proteome were excised 
and destained, followed by a standard in-gel reduction and alkylation using dithiothreitol 
and iodoacetamide, respectively. Proteins were then in-gel digested overnight and the 
resulting peptide mixture was extracted by sonication of the gel slices in a solution of 5% 
formic acid in 25% acetonitrile, and finally concentrated at 40 °C in a speed-vac.  
For mass spectrometric analyses, peptides were resuspended in a solution of 0.05% 
trifluoroacetic acid in 2.5% acetonitrile prior to filtering using a 0.22 µm cellulose acetate 
spin column. Samples were analyzed by nanoLC-ESI-MS/MS with an Ultimate 3000 LC 
system (Dionex-LC Packings) coupled to an Orbitrap Fusion mass spectrometer (Thermo 
Scientific) using a 60 minutes LC separation on a 25 cm column and settings as previously 
specified (Christie-Oleza et al., 2015). 
Raw mass spectral files were analyzed using Qual Browser from the software Xcalibur 
(version 2.2). Ions of interests were identified manually by plotting the appropriate mass 
ranges. Charge state was confirmed by calculating the mass differences observed 
between related peaks from isolated ion spectra (Appendix 7). Volcano plots were based 
upon data analyzed with Perseus, using the pipeline and settings previously described in 
Material and Methods of Chapter 3 (section 2.3.). 
 
5. Bioinformatics 
5.1.  PPTase identification 
Hypothetical PPTases in S. tropica CNB-440 are listed by Kim and colleagues in Table S1 
of their study (Distribution of PPTases in Actinomycetales microorganisms and some 
eubacteria): strop_0685, strop_0777, strop_2496, strop_2822 and strop_3859 (Kim et al., 2018). 
To confirm that they are PPTases, we analyzed their sequence alignments, with the sfp 
from Bacillus subtilis as a reference (GenBank accession number AEK64474.1) using 
CLUSTAL multiple sequence alignment by MUSCLE (3.8) 
(https://www.ebi.ac.uk/Tools/msa/muscle/; Madeira et al., 2019) and ESPript (3.0) for 
annotation (http://espript.ibcp.fr; Robert & Gouet, 2014). 
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5.2.  ACP/PCP identification 
A Hidden Markov Models (HMM) profile for the ACP, PCP, ACPS, and ACP_beta domains 
was extracted from the “nrpspksdomains.hmm” file which is included in the antiSMASH 
software package using the binary program hmmfetch. These profiles were used to 
query the genome of S. tropica CNB-440 (UP000000235) using hmmsearch. The default 
threshold cutoffs were used for the query using the flag “—cut_tc.” Hmmfetch and 
Hmmsearch are part of the hmmer suite of programs (http://hmmer.org/, v3.2.1) 
 
Figure 23 | S. tropica has four PPTases responsible for activation of its NRPSs and PKSs. (A) 
Amino-acid sequence alignments of identified PPTases in S. tropica CNB-440 with B. subtilis Sfp. 
Amino-acids with strict identity are highlighted in red. Amino-acids within a blue frame are 
similar across sequences. (B) Genomic map of S. tropica CNB-440, showing BGCs (outer ring) 
and identified PPTases locations (inner ring). Genome size is 5,183,331 bp. BGCs are labelled in 
orange if characterized and in green if orphan. 
 
RESULTS 
Identification of PPTases in S. tropica CNB-440 
In order to delete PPTases for the broad inactivation of BGCs in S. tropica, we were 
interested in identifying and locating its PPTases linked to secondary metabolism only 
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(PKS and NRPS). There are indeed two subfamilies of PPTases: the AcpS-type is required 
for fatty acid biosynthesis (i.e. primary metabolism) and the Sfp-type for polyketide and 
non-ribosomal peptide biosynthesis (i.e. secondary metabolism; Beld et al., 2014; 
Lambalot et al., 1996). 
Previous studies have identified bioinformatically at least five putative PPTases encoding 
genes in the genome of S. tropica CNB-440, namely strop_0685, strop_0777, strop_2496, 
strop_2822 and strop_3859 (Kim et al., 2018; Udwary et al., 2007). Alignment of their 
amino-acid sequences confirmed that they possess the highly conserved regions ppt-1 
[(I/V/L)G(I/V/L/T)D(I/V/L/A)] and ppt-3 [(F/W)(A/S/T/C)xKE(S/A)h(h/S)K(A/G)] that are 
characteristic of PPTases (Fig. 23, A; Lambalot et al., 1996). Interestingly, mapping the 
PPTases to the S. tropica genome showed that they are all located within a BGC or nearby 
(i.e. strop_0777 being 75 kb away from nrps1; strop_0685 within nrps1; strop_2496 
within pks3 and strop_2922 within slm), with the exception of strop_3859 which is 300-
kb away from its closest BGC (i.e. spt; Fig. 23, B). 
We found the location of the PPTases to be consistent with their putative function. The 
number of amino-acids n between the ppt-1 and ppt-3 motifs is specific to the PPTase 
subfamilies, with n between 42-48 aa for the AcpS-type and 38-41 aa for the Sfp-type. 
As such, we identified the PPTases 0685, 0777, 2496 and 2822 to be involved in 
secondary metabolism, with n = 38, 36, 39 and 38, respectively; and the PPTase 3859 to 
be involved in primary metabolism, with n = 42 (Fig. 23, A). Based on DNA sequence 
analysis and the genetic context of the identified PPTases, we ultimately hypothesized 
that the four PPTases 0685, 0777, 2496 and 2822 are responsible for the functional 
activation of S. tropica’s BGCs. 
 
Genomic deletion of PPTases and NRPS clusters in S. tropica using CRISPR/Cas9 
While previous studies used well-established integrative vectors and PCR-targeted 
mutagenesis to create Salinispora mutants, the CRISPR/Cas9 technology has, to date, not 
been applied in the genus Salinispora (Bucarey et al., 2012; Eustáquio & Moore, 2008). 
In order to knock-out the selected PPTases, we chose to use the pCRISPomyces-2 vector 
(Fig. 24, A), a CRISPR/Cas9-based system optimized for genome editing of Streptomyces 
(Cobb et al., 2015). We modified the pCRISPomyces-2 plasmid to delete the PPTases 
0685, 0777, 2496 and 2822, by cloning in the corresponding protospacers and homology 
 71 
arms (Table 6; Fig. 24, B). We also decided to delete the orphan nrps1 and nrps2 gene 
clusters based on proteomic data obtained by our group that suggested they could be 
linked to the cryptic molecules and/or the antimicrobial activity observed in co-culture 
(see Chapter 3). For this, we similarly retargeted the pCRISPomyces-2 vector for those 
BGCs and then worked towards transferring the six modified CRISPR vectors into S. 
tropica. 
 
Although transfer of plasmids in Salinispora via conjugation has previously been 
reported, we found the successful implementation of this technique to be non-trivial. 
We were unable to obtain any exconjugant using a published protocol (Eustáquio & 
Moore, 2008) despite numerous attempts, which warranted extensive efforts into the 
development of a modified method efficient for the transfer of DNA in S. tropica, which 
we discuss in detail later in the thesis. Some differences were, for instance, the use of (i) 
an auxotrophic E. coli donor strain allowing screening of exconjugants without the 
addition of nalidixic acid, (ii) spores sourced from solid medium, (iii) cell spotting for 
mating and (iv) reduced apramycin concentration added in-plate rather than overlayed. 
Following this altered protocol, the conjugal transfer of our retargeted pCRISPomyces-2 
plasmids to S. tropica yielded on average 1-8 exconjugants per plate. We successfully 
isolated exconjugants for all of our plasmids with the exception of pCRISPomyces-2822, 
resulting in the S. tropica strains 0685, 0777, 2496, nprs1 and nrps2. 
 
Figure 24 | Plasmid maps of the CRISPR/Cas9-based pCRISPomyces plasmids used for genomic 
deletion. (A) Map of the original pCRISPomyces-2 vector (Cobb et al., 2015). (B) Generic map of 
the retargeted pCRISPomyces for deletion of PPTases constructed in this study. The 
endonuclease cas9 (cas9) is guided by a 20-bp CRISPR RNA (protospacer) completed with a 
guide RNA scaffold (green arrow). Homology arms (HA) used as editing template for 
homologous recombination can be cloned into the XbaI site. Apramycin resistance marker 
(ApraR) allows selection in both E. coli and Streptomyces. The colE1 origin (ori) allows for 
















We then screened the obtained exconjugants by PCR to confirm the deletion of the 
genomic regions of interest. We were able to isolate colonies of the strains S. tropica 
0777, 2496 and nrps2, that appeared to have the expected deletions whereas the strains 
0685 and nrps1 gave unexpected results. Indeed, when screening colonies of S. tropica 
0685, we were intriguingly unable to amplify the region flanking the PPTase 0685 but we 
were able to in the wild-type strain (Fig. 25, A). While the integrity of the gDNA extracted 
from this strain was verified using a primer pair amplifying an untargeted region of the 
genome, no amplicon could be obtained with various oligonucleotide pairs binding up to 
 
Figure 25 | PCR verification of exconjugants. (A) PCR check of PPTase 0685 deletion. Expected 
size for the wild-type strain is 2,622 bp and 1,940 bp for the ∆PPTase 0685 strain. Lane labelled 
∆0685+ shows control PCR to confirm integrity of the gDNA used for lane labelled ∆0685, with 
another primer pair that binds outside the targeted region, with an expected amplicon of 1,947 
bp. (B) PCR check of PPTase 0777 deletion. Expected size for the wild-type strain is 2,784 bp 
and 2,050 bp for the ∆PPTase 0777 strain. (C) PCR check of PPTase 2496 deletion. Expected size 
for the wild-type strain is 2,642 bp, and 2,142 bp for the ∆PPTase 2496 strain. (D) PCR check of 
BGC nrps1 deletion. With the primer pair 95-96, which binds within the cluster, expected size 
for the wild-type strain is 892 bp and no amplicon for the ∆nrps1 strain. With the primer pair 
97-98, which binds outside the cluster, expected size for the wild-type strain is 40,700 bp and 
571 bp for the ∆nrps1 strain. (E) PCR check of BGC nrps2 deletion. With the primer pair binding 
outside the cluster, expected size for the wild-type strain is 34,711 bp and 2,448 bp for the 
∆nrps2 strain. PCR products were run on a 1% agarose gel with a 1 kb plus ladder (Invitrogen).  
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2,4 kb away from the sites of deletion. This observation suggested an unsuspected 
recombination event that would require further investigation. Concerning the nrps1 
deletion, despite extensive screening, no apramycin-resistant clone of the strain S. 
tropica nrps1 tested showed the loss of the corresponding BGC (Fig. 25, D).  
On the other hand, screening of the strains S. tropica 0777, 2496 and nrps2 showed the 
apparent deletion of the corresponding genomic regions (Fig. 25, B, C and E). As genome 
editing using CRISPR/Cas9 is marker-less, the obtention of mixed populations of wild-
type and mutant cells is to be expected and has been previously reported (Cobb et al., 
2015). We obtained such mixed population with the strain S. tropica 0777, as PCR 
screening revealed dual amplicons corresponding both to the correct deletion of the 
PPTase 0777 and the wild-type genomic region (Fig. 25, B). Isolation of the mutant cells 
from the wild-type population was carried out but unsuccessful. We were able to 
confirm, however, the successful genomic deletion of the entire nrps2 gene cluster (> 34 
kb deletion) and the PPTase 2496 (501-bp deletion), resulting in the two strains Dnrps2 
and D2496, respectively (Fig. 26; Table 6). Regrettably, we worked with a mixed 
 
Figure 26 | Genomic deletion of the PPTase 2496 and nrps2 BGC in S. tropica. The deleted 
regions of the PPTase 2496 (A) and the nrps2 BGC (B) are depicted in shaded yellow, with their 
sizes indicated. Un-modified regions are filled in yellow. Sanger sequencing of the engineered 
genomic regions issued from the corresponding S. tropica ∆2496 and ∆nrps2 strains are shown. 








population mutant/wild-type of the strain S. tropica nrps2, that we did not detect 
because of our primer design, and subsequent cultures lead to the loss of the 
recombinant strain. The reasons for the difficulties encountered in isolating the mutants 
are further discussed below in this Chapter. Meanwhile, the strain S. tropica D2496 was 
successfully isolated as a pure culture and used for the ensuing experiments.  
 
Characterization of the S. tropica mutant strain D2496 
Having shown the efficacy of CRISPR/Cas9 to generate knock-out mutants in S. tropica, 
we set out to determine whether the deleted PPTase 2496 could be linked to the 
biosynthesis of the cryptic molecules and/or the antimicrobial activity observed against 
phytoplankton (see Chapter 2). Interestingly, the gene encoding this PPTase is located 
within the orphan pks3 BGC (Fig. 23, B), a cluster we have shown to be active that is 
thought to produce an unidentified spore pigment polyketide (Kersten et al., 2013). Due 
to this specific location, we hypothesized that the PPTase 2496 was likely to be 
responsible for the activation of the ACP/PCP domains of the pks3 BGC, therefore directly 
impacting the biosynthesis of the pks3-encoded compound. 
 
Figure 27 | The mutant strain S. tropica ∆2496 has the same antimicrobial activity and 
metabolome than the wild-type strain. (A) Both the wild-type (blue line) and ∆2496 (green line) 
S. tropica strains inhibit Synechococcus growth in co-culture. Graph shows mean ± standard 
deviation of three biological replicates. (B) The production of the cryptic molecules 4, 6 and 7 
is not abolished in the mutant strain S. tropica ∆2496. Graph shows extracted ion 
chromatograms for all three cryptic molecules EIC (464.2; 435.2; 449.2) ± 0.5 in the 
concentrated supernatants of the S. tropica wild-type strain (blue) or the ∆2496 strain (green) 



















































































































































































To test this, we first co-inoculated the phototroph Synechococcus with either the wild-
type strain S. tropica CNB-440 or the mutant strain D2496 and compared their 
antimicrobial activity profile (Fig. 27, A). The PPTase-deficient mutant was still able to 
inhibit the growth of the phototroph, suggesting that the PPTase 2496 is not required for 
the antimicrobial ability of S. tropica. We also analyzed by LC-MS crude extracts obtained 
from the co-culture supernatants, allowing us to detect the cryptic compounds 4, 6 and 
7 produced by the mutant and wild-type strains alike (Fig. 27, B). Additionally, we studied 
their total metabolomes and looked for any differences (i.e. loss of molecule) but we 
could not identify such change. This observation similarly suggested that the deletion of 
the PPTase 2496 did not influence the secondary metabolism of S. tropica. 
Considering the absence of differences in phenotype between the wild-type and D2496 
S. tropica strains, we were interested in assessing by proteomics whether deletion of the 
PPTase 2496 actually prevented activation of the ACPs/PCPs of the pks3 BGC.  
 
The ACP domain of the pks3 BGC is not activated only by the PPTase 2496 
In order to investigate whether the PPTase 2496 was solely responsible for the activation 
of the pks3 cluster, we used proteomics to detect the post-translational modifications of 
the ACPs/PCPs in the wild-type and mutant S. tropica strains. PPTases indeed activate 
apo-PCP domains into their active holo-form by covalently installing a PPant moiety to a 
conserved serine. As such, holo-PCPs can be detected in proteomics data by searching 
for the appropriate peptides bearing the added mass of a PPant group. 
For this, we first identified all ACP/PCP domains in S. tropica’s genome using an HMMER 
search combined with antiSMASH. The bioinformatic analysis carried out resulted in the 
detection of 41 putative ACPs/PCPs, of which one was located within the pks3 cluster 
(Fig. 28). We found, indeed, a single ACP site in the strop_RS12595 gene with the highly 
conserved serine residue that we expected to be PPTase-modified. Based on the amino-
acid sequence of the corresponding protein A4X7U8, we calculated the mass of the 
predicted peptide to contain the conserved serine residue after tryptic fragmentation 
(Fig. 29, A). Considering no miscleavage of the protein, the 26-amino-acid peptide is 
expected to weight 2640.3752 Da in its apo-form. Considering the PPTant moiety (i.e. 
340.0858 Da) as well as the iodoacetamide derivation (i.e. 57.0215 Da) used in our 
sample preparation, we anticipated the mass of the holo-ACP fragment to be 3037.4825  
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Da (Fig. 29, B). Finally, we calculated the mass over charge ratio (m/z) of the 
corresponding ions that would effectively be detected by the mass spectrometric 
instrument. The adducts had m/z 1519.7412, 1013.4942, 760.3706 and 608.4965 
corresponding to 2, 3, 4 and 5 positive charges, respectively (Fig. 29, C).  
We generated the proteomes of the wild-type and D2496 S. tropica strains and we 
looked for the ACP-peptide belonging to the pks3 BGC. Surprisingly, we found in both 
strain its active form bearing the PPant moiety, at a retention time of 38 minutes (Fig. 
30). The holo-ACP fragment was reliably detected by MS as its corresponding ions were 
identified for all four charge states calculated (Fig. 30; Appendix 7). This observation 
made in the PPTase 2496-deficient strain indicated that the pks3-encoded ACP is 
modified by functionally redundant PPTases, as its activation appeared independent of 
the PPTase 2496.  
 
Deletion of the PPTase 2496 impacts the abundance of several pks3-encoded proteins  
Lastly, we queried the total proteomes of the wild-type and D2496 S. tropica strains for 
any differences that may have resulted from the deletion of the PPTase. As expected, we  
 
Figure 28 | Identification of putative ACP/PCP sites in S. tropica’s genome. Amino-acid sequence 
alignments of all ACPs/PCPs in S. tropica CNB-440. Sequences were identified based on an 
antiSMASH and HMMER search. The highly conserved serine residue expected to be modified 
by PPTases is highlighted in red. The ACP domain identified within the pks3 BGC is in bold. 
Identifiers show locus name (strop_), ACP/PCP domain position (amino-acid number) and the 
gene cluster in which the sites are.  
 
RS03450  17-59  nrps1
RS13940  18-75  slm
RS12595  16-64  pks3
RS11190  28-78  lom
RS11205  52-104  lom
RS13900  79-152  slm
RS13900  7057-7129  slm
RS13900  3551-3623  slm
RS13900  5290-5361  slm
RS13900  1819-1889  slm
RS13955  1431-1504  slm
RS13965  3313-3384  slm
RS13960  2874-2947  slm
RS13950  1649-1719  slm
RS13965  1630-1702  slm
RS13960  1368-1441  slm
RS13950  3356-3428  slm
RS15300  552-624  lym
RS15300  1592-1663  lym
RS13320  589-657  sid2
RS13355  1373-1440  sid2
RS14155  1434-1509  sid4
RS14160  1059-1128  sid4
RS05180  512-583  sal
RS22290  1002-1070  nrps2
RS22285  1037-1105  nrps2
RS14085  977-1045  sid3
RS22305  528-594  nrps2
RS13695  511-578  sid2
RS22305  1613-1680  nrps2
RS14160  2091-2158  sid4
RS03480  476-541  nrps1
RS13320  17-84  sid2
RS13360  1228-1284  sid2
RS03405  985-1053  nrps1
RS14080  4-71  sid3
RS13360  11-80  sid2
RS05185  1448-1516  sal
RS05185  16-82  sal
RS03400  17-70  nrps1
RS14035  10-76  slm
                   1       10         20            30          40                 
STROP_RS03450_17_59AA_NRPS1                                       S                                              I ELG D M AI L I G V MP LL D...................TQP TSEASLQ. L R ....E LFT EDTY .. S DE T ...............
STROP_RS13940_18_75AA_SLM                                         S                                              L D G D LAMV L L V AM A..................PEEP LDGTSLH. S L ....E LAT ESEYN.. RFVDD SLETF TPQTLWSAIR.
STROP_RS12595_16_ 4AA_PKS3                                        S                                              V G ELG D LALL L V V IP.......L AHC ..LNAADAARAPAASLE. M ....E SAV ADRWQ.. R EE...................
STROP_RS11190_28_78AA_LOM                                         S                                              F DLG D LALL S I G V L AL E T LV V.......................APERA A. Y ....ETQ V RREY .. D SEQ S AE PQQ DL N...
STROP_RS11205_52_104AA_LOM                                        S                                              F ELG D LALL S I G V I L T MV I.......................APDQP D. Y ....ETH R KRDY .. V SEDD ERVH PRA EF NDH.
STROP_RS13900_79_152AA_SLM                                        S                                              V VL V F DLG D LAAV L L G L LPV LIFD PT V L.AL REQARD RTVLPDGPEA EPGRP R. F ....E HRR IAAT .. D T H PQA GRL RT..
STROP_RS13900_7057_ 129AA_SLM                                     S                                              V A VLG I F ELG D LAAV N L G L LPA LIYD PS A VA V.EL RARA E ..H.DRPNA DPDRG L. F ....EFR S GAAT .. R T H P A RF RSEL
STROP_RS13900_3551_3623AA_SLM                                     S                                              V A VLG V F ELG D LAAV L N L G L LPA LVFD PN LA LLDL RAAV A ..H.DSVTT EPARA K. F ....E R G NAGT .. R T Y PTA DY HSR.
STROP_RS13900_5290_5361AA_SLM                                     S                                              V A VLG V F ELG D LAAV L N L G L LPA LVFD PN LA LLDL RAAV A ..H.DSVTT EPARA K. F ....E R G NAGT .. R T Y PTA GY HR..
STROP_RS13900_18 9_1889AA_SLM                                     S                                              I A VLG I F EVG D LAAV L N L G L LPA LVFD PT A LA V.DL RVHV A ..H.DGSAA EPRRA N. F ....E R R NAAT .. R T Y P A EF VS..
STROP_RS13955_1431_ 504AA_SLM                                     S                                              V A VLG V F DLG D V AV L N L G L L A LVFD PT L LA LLDT RTNV A ..Y.GDADS EPRRA K. M T ....E R R SAAT .. R S T H P A DQ RAEL
STROP_RS13965_331 _ 384AA_SLM                                     S                                              V A VLG V F DLG D LAAV N L G L LPA LVFD P A LA LLDL RTHA A ..F.PGPAS EPGRA K. F ....EFR V STVT .. R T H EP A RA KA..
STROP_RS13960_2874_2947AA_SLM                                     S                                              V A VLG V F EAG D L AV L N L L LPA LVFD PT I LA LLAL RDQV A ..Y.ASDAD EPERA K. F T ....E R R ATETA.. R T H P E RH LTEL
STROP_RS13950_1649_1719AA_SLM                                     S                                              V A VLG V F LG D L AV L N L G L LPA LIFD PT L L L.HL NTHV A ..L.SGPDA EAERT Q.S F T ....E R A STAA .. R T Y P A TEL HR..
STROP_RS13965_1630_1702AA_SLM                                     S                                              V A VLG I F ELG D L AV L N L G L LPA LIFD PS LA LTAL LTQV A ..H.ASAER DAGRP Q. F T ....E R A SAST .. R T Y PRD RY LRE.
STROP_RS13960_1368_1441AA_SLM                                     S                                              V A VLG V F ELG D L AV L N V G L LPA MVYD PT A LA LLDT RTHV V ..Y.DASTT DVQRP R. F T ....E R A GEAV .. R T H P V RH YDEL
STROP_RS13950_3356_3428AA_SLM                                     S                                              V A VLG V F ELG D L AM L N L G L L VVFD GSIA LA L.DL RTRA T ..H.TRPDD DPALR V. F T ....E R A NEVT .. R DTG H E AL RTEL
STROP_RS15300_552_624AA_LYM                                       S                                              V A AVG I F DLG  LAVV V Q L G L LPA VVFD PT LA LLEL RSEV R ..L.DSAEQ RPDQP V. LG ....G G R CARV .. R T H PTA AR VAE.
STROP_RS15300_1592_1663AA_LYM                                     S                                              V A VLG I DLG D L AV L N I G V LPA LVFE PTVA LA L.QT TALV A ..H.ADPDE DPDASLL. F T ....E R Q RDLS .. N S F V DH LSR.
STROP_RS13320_589_657AA_SID2                                      S                                              I A MLG F LG D LLAV M L V D PTVA LA VERT ADHW A ......CGVPDRAAN F.G G ....R LGA AREK..VGR TPRRFL R G SA RE..
STROP_RS13355_137 _1440AA_SID2                                     S                                              L LLG F LG  LLA M L V L L L PTVA LA LEAT AKVWSE ......FDVSDRDAD F.A GH T....R LAR RDEH..G Q R QD LAR S AL P...
STROP_RS14155_143 _1509AA_SID4                                     S                                              L A AL V ELG D LVAA V N I L V E PTVA LA IERG AAVW E R......VPR GRDENLF. G QITGR L E PQAANLFFDQV RQ L Q A GH EAE.
STROP_RS14160_1059_1128AA_SID4                                     S                                              V A LLG V F AG D LVA S L V A L LF P L A LERD ARIW E ......VPA GRRQT F.A G ..I..RSM L ATAG..L G N RQ AT A CDF AT RRG.
STROP_RS05180_512_583AA_SAL                                       S                                              L LL I F DLG  LLLV L M VGV LF I LA LEQA AEIWGA DR....TPQS GIRDT Y. GN ....R AKR GQRFH..RK AD RFRD GS KW DDE.
STROP_RS22290_1002_1070AA_NRPS                                     S                                              L VL I F LG  LL A A S I VPI ILFE PTI MA LEQL AGIWQE H......VER GVLDD F.R GH G ....Q L R GAVLE..TE R A DA RA RS..
STROP_RS22285_1037_1105AA_NRPS                                     S                                              L A LL V F DLG  LLAA L T I G V LPL ALF LA LA LEKT AGIW E D......TNP GRHDN F. GH ....S A R RAAL .. E R STAD G AV DG..
STROP_RS14085_977_1045AA_SID3                                     S                                              L LL I F LG  L AA L N V G A LPL ALY TVA L LEHQ VALWSS D......QPS GVDDG F.A GS Q ....Q M R EREF .. R A QHS E GRL DA..
STROP_RS22305_528_594AA_NRPS2                                     S                                              L LLG F LG  LLV L V G V LPV IVYE PTLA LA L..R AALWTE ......SSPSTPDDD F.A GN T....R TFV ADRF .. D R H G GV GE..
STROP_RS13695_511_578AA_SID2                                      S                                              L A VLG I F DLG  L AM L S I G V L I FD PTVA L LEKL LSLF D ......VDR GVNDG F. GQ Q ....R I R RTTL .. D T SDF A D DAH T...
STROP_RS22305_16 3_1680AA_NRPS                                     S                                              L VLG V F LG  L A L I G V L L LF PTVA LA VEAQ ITLWQD ......RTE GVHDN F.A GH T T....R IAR RTVF .. E A RS AA E VQ A...
STROP_RS14160_2091_2158AA_SID4                                     S                                              I V VL L F LG D LLA L L G V L L LF PTVA LAEKL AELW E D......CDQ GRQQS F.A G T....R VEL RQRH .. E S RE LA Q DVFD...
STROP_RS03480_476_541AA_NRPS1                                     S                                              I VLG A F VG  L AL L L V I PT MA L... FAAWTD ......APP GTDVN F.A GN S ....R VDM TADGR..PA D VRWLGD PQR DL GN..
STROP_RS13320_17_84AA_SID2                                        S                                              A VL V F LG D VL V M V G V L L V SAA LA I....RGVW D DV....DVTA PADAS L.S G T ....R AAL RQRL .. A A VD RVEH R AL QER.
STROP_RS13360_1228_1284AA_SID2                                     S                                              V F LG  L LV L L L MF TVA LA I.........TG.........EP RADST A.G VT T ....LTHRR RESVA..PH A AD GHA S AH TA..
STROP_RS034 5_985_1053AA_NRPS1                                     S                                              L VL I E G  L I V G V VPL F PTVA LA IERD AGLWGR D......VEG QPDRPLI. Y AH N F....TTLAE QEHY .. A VDF AT T EL RA..
STROP_RS14080_4_71AA_SID3                                         S                                              M I F DL D MAAA L V G V LPL VFD PT A LL V.QR RKVWEY FQ......QAVTDDSDF I. DG ....A VHH AEEF .. S FE R P E AA RD..
STROP_RS13360_11_80AA_SID2                                        S                                              V A VLG I LG E AV L I G LPL A TA LA L.DD LDCI E ....MDPEL DVQASLT.A L FT ....R RRR RERT ..QD T FLGNA TH RH SD..
STROP_RS0518 _1448_1516AA_SAL                                     S                                              I A VLG L D G D MLAM L S I G V L F TV L I..T TGEI H ....MPVEE AEGTRLR. F L ....R G R QTLF ..HR S FEF TDR GE TAR AE..
STROP_RS0518 _16_82AA_SAL                                         S                                              L V LLG V G D L L L VPI LWD PTL L L... LTWL D ....VPRDS DRWAPLH.RY L KST....A VAA SEFLA..RP TF H EG SVA A...
STROP_RS034 0_17_ 0AA_NRPS1                                       S                                              EAG E L LL L L A I A L D TV L L.....................AFDDSTPLL. L S ....R AVE ANDDD.. E D TR V LR GD KQW HE..




found little variations in their proteomes but for five proteins that were downregulated 
in the mutant strain when grown in SUPSYN (Fig. 31, A).  
Interestingly, three of these are encoded within the pks3 BGC (i.e. A4X7U0, A4X7T8 and 
A4X7T5; Fig. 31, B). The protein A4X7T1 is most likely also involved in the pks3 
biosynthetic pathway, although not formally described as belonging to the cluster, 
because its corresponding gene is located directly downstream the BGC and is part of 
the same transcription unit as the genes encoding the three previously mentioned 
enzymes (Fig. 31, B). While an antiSMASH analysis coupled with a blastP search identified  
 
Figure 29 | Mass of the ACP-peptide from the pks3 BGC estimated for MS detection. (A) Amino-
acid sequence of the protein A4X7U8 that belongs to the orphan pks3 BGC. Sequence of the 
peptide resulting from tryptic digestion that contains the conserved serine residue (highlighted 
in red) predicted to bear the PPant moiety is underlined. (B) The peptide is also depicted with 
its serine residue (red) modified with a PPant group (orange) and with the iodoacetamide 
derivation (blue). (C) Calculated masses of the ions corresponding to the holo-ACP peptide 



















































1 2641.3752 2981.4610 3038.4825
2 1321.1876 1491.2305 1519.7412
3 881.1251 994.4870 1013.4942
4 661.0938 746.1153 760.3706
5 529.0750 597.0922 608.4965
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A4X7U0 and A4X7T8 as core polyketide biosynthetic proteins, the function of A4X7T1 
could not be predicted (Table 7). Additionally, this protein was the only one to be 
significantly less abundant in the mutant strain compared to the wild-type when cells 
were grown in MB (Fig. 31, A). The fifth downregulated enzyme A4X6H0 did not belong 
to any reported BGCs and was also of unknown function (Table 7).  
The genes encoding the PPTase 2496 and the proteins A4X7U0, A4X7T8, A4X7T5 and 
A4X7T1 are remarkably oppositely oriented in the same bidirectional operon (Fig. 31, B). 
We therefore hypothesized that the proteins downregulation could be caused by an 
alteration of the genes’ transcription, although the PPTase deletion conserved the entire 
intergenic region (i.e. sequence comprised between strop_2495 and strop_2496) that 
should contain the bidirectional promoter. In an attempt to verify this, we screened the 
promoter region of the operon using various tools (i.e. GBpro Genome Browser, 
iPromoter-2L and BPROM) but they failed to identify any bacterial promoters or 
regulatory elements within the queried sequence. Future work based on 
 
Figure 30 | Deletion of the PPTase 2496 does not abolish activation of the ACP site within the 
pks3 BGC. MS analysis detecting the PPTase-modified peptide of protein A4X7U8, at different 
charge states, in the proteome of the S. tropica wild-type strain (Wild-type, right panel) or the 
∆PPTase 2496 strain (∆2496, left panel) grown axenically for 5 days in MB. Chromatograms 
show mass ranges m/z 1519.74-1520.74 (black), 1013.49-1014.49 (red), 760.37-761.37 (green) 











complementation experiments should be carried out to confirm whether the observed 




We demonstrated for the first time the use of the CRISPR/Cas9 technology to genome 
engineer the genus Salinispora. We successfully deleted the PPTase 2496 and the entire  
nrps2 gene cluster, representing more than 34 kb of the S. tropica genome (Fig. 26). 
These genomic deletions resulted in the two CRISPR-induced mutant strains D2496 and 
Dnrps2, respectively (Table 6). 
 
Figure 31 | Several pks3-encoded proteins are downregulated in the PPTase 2496-deficient 
strain. (A) Volcano plots of the comparative proteomic analysis of the S. tropica wild-type and 
∆PPTase 2496 strains grown for 5 days in marine broth (MB, left panel) or in a phototroph 
supernatant (SUPSYN, right panel). Red curve represents a false discovery rate (FDR) of 0.05 
and s0 of 2. The IDs of significantly differentially expressed proteins are given. These proteins 
are colored in red or blue if they are encoded within the pks3 BGC. (B) Representation of the 
pks3 cluster. Genes are depicted in red if their corresponding proteins were detected in the 
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Obtention of those mutant strains, however, has proven extremely challenging. First, 
conjugal transfer of plasmids into S. tropica failed using already established protocols 
(Eustáquio & Moore, 2008; Netzker et al., 2016) and required the development of a 
successful method via a lengthy trial and error approach. Based on the observations 
made from numerous attempts, we hypothesize that antibiotic concentrations, 
condition of cell mating and spore preparation are some key factors for efficient DNA 
transfer in S. tropica. Employing an auxotrophic donor strain, for instance, allowed us to 
decrease the amount of antibiotic used for exconjugant selection, which we believe 
concurrently helped to decrease the metabolic burden and stress on the recombinant 
cells (Allard et al., 2015). Also, spotting donor and recipient cells for mating increased 
cell-to-cell contact compared to spreading cells as a layer onto solid medium. Lastly, 
while the published protocol reports the obtention of spores from only 1 mL of a 3-day 
old Salinispora liquid culture in A1 medium (Eustáquio et al., 2009) we collected a very 
limited number of spores this way. Instead, we found that growing Salinispora as a dense 
cell lawn onto solid media for 30 days resulted in a far greater number of spores (despite 
being a longer process), as it is more commonly done with Streptomyces species 
(Shepherd et al., 2010). 
 
Table 7 | Differentially expressed proteins in S. tropica D2496 vs wild-type. 
 
a Core biosynthetic enzyme. 
b No significant similarity found based on the UniProtKB/SwissProt sequences database. 
 
Although we were able to ultimately obtain a few successful exconjugants using our 
improved protocol of conjugation, the CRISPR/Cas9 system presented several drawbacks 
for the generation of mutants in Salinispora. The pCRISPomyces-2 vector contains a 
temperature-sensitive origin of replication allowing plasmid curing when growing cells 
at 39 °C or above (Cobb et al., 2015) but S. tropica does not grow at this temperature. 
Protein ID Homologue (% identity/% similarity)Organism [Protein ID] Putative function
A4X7U0
fabF (34/53)














We have attempted plasmid curing by passaging isolated exconjugants in fresh medium 
without antibiotic selection for up to five months without success. Experiments 
described in this manuscript were therefore performed using the mutant S. tropica strain 
still bearing the pCRISPomyces plasmid, which could have impacted the cell fitness as 
well as caused additional undesired genomic deletions. Additionally, the absence of 
selection marker for the deletion event leads to the isolation of mixed populations of 
wild-type and mutant cells (Cobb et al., 2015). Our S. tropica Dnrps2 strain was, for 
instance, lost through subculturing because of this marker-less editing. The S. tropica 
population bearing the pCRISPomyces-0777 vector was also made of mixed cells (Fig. 25, 
B). Unfortunately, we were unable to isolate a pure culture of the mutant due to the 
aggregation of Salinispora cells as both dense clumps in liquid and tough colonies on 
solid, preventing us from further characterizing the strain. Future knock-outs will 
therefore require a better separation technique of exconjugants to obtain pure cultures. 
Lastly, our difficulties in isolating nrps1- and PPTase 0685-deficient cells in any of the 
corresponding apramycin-resistant exconjugants that we tested, are most likely due to 
off-target or poor on-target performance of the CRISPR/Cas9 cleavage. This observation 
highlighted the importance to design multiple synthetic guide RNA for future genome 
editing attempts, as the efficiency and specificity of the Cas9 endonuclease varies 
depending on the protospacer target sequences selected (Fu et al., 2014; Graf et al., 
2019). 
Of the six genomic deletions tested, we finally only obtained the strain S. tropica D2496 
as a pure culture, allowing us to assess its potential involvement in the biosynthesis of 
the cryptic molecules and/or antimicrobial activity observed against Synechococcus. 
Data revealed that the mutant strain has the same metabolome and killing phenotype as 
the wild-type S. tropica (Fig. 27). To understand this, we investigated whether the 
deleted PPTase 2496 was solely responsible for the activation of the pks3-encoded ACP 
domain we identified through bioinformatic analysis. Using proteomics to detect the 
post-translational modifications of this ACP site, we showed that it was activated through 
the addition of a PPant moiety in both the PPTase 2496-deficient and the wild-type 
strains (Fig. 30). PPTases are generally dedicated specifically to the biosynthesis of the 
molecule produced by the BGC in which their encoding genes are located, or to distinct 
sets of BGCs (Stanley et al., 2006). It has been previously reported, however, that some 
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PPTases found outside secondary metabolite clusters can be ambiguously involved in 
multiple biosynthetic pathways (Bunet et al., 2014). In S. tropica, due to its location 
outside any BGCs, we hypothesize that the PPTase 0777 may play this pleiotropic role 
and act as a functionally redundant PPTase compensating the absence of the PPTase 
2496 in the mutant strain S. tropica D2496 (Fig. 23, B). In order to successfully implement 
our desired approach for the broad inactivation of diverse BGCs by single PPTase-gene 
deletion, future work will therefore depend upon the prior knock-out of this putative 
pleiotropic PPTase 0777. The resulting S. tropica D0777 mutant could then be used as a 
starter strain for further genome editing steps, which the marker-less deletions created 
by CRISPR/Cas9 would facilitate.   
Lastly, a comparative analysis of the proteome of the S. tropica wild-type and ∆PPTase 
2496 strains indicated that several enzymes encoded within the pks3 gene cluster were 
significantly downregulated in the mutant (Fig. 31). We were unable to verify whether 
these variations were caused by a polar effect of the PPTase 2496 deletion and 
complementation experiments should be carried out to confirm this. Interestingly, the 
difference in abundance of those core biosynthetic enzymes was not reflected in the 
metabolome or antimicrobial profile of the strains (Fig. 27). This observation suggests 
that the product of the pks3 BGC is not detected in our experimental setup. It also 
supports our hypothesis that the cryptic compounds and antimicrobial activity reported 
in Chapter 2 are not related to pks3 but rather the nrps1 cluster.  
Additional research efforts will focus on optimizing the conjugal transfer of plasmids in 
S. tropica to obtain better yields. These would involve, for instance, testing different 
ratios of donor and recipient cells, as well as reducing Salinispora clumping for better 
spore isolation. Also, conjugations of the retargeted pCRISPomyces-2 plasmids will be 
repeated to delete the PPTases 0685, 0777 and 2822, as well as the two nrps1 and nrps2 
gene clusters. Analysis of the mutants metabolic and antimicrobial profiles should allow 
to link the production of the cryptic metabolites with a specific orphan BGC. Ultimately, 
our study pioneers the application of the CRISPR/Cas9 technology in the genus 
Salinispora and lays the foundation for its use as a potentially faster, marker-less and 
multiplex genome editing method. This new tool should facilitate and accelerate the 
study of Salinispora for the discovery of novel natural products.  
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C H A P T E R  5  |   
F I N A L  C O N C L U S I O N S  A N D  F U T U R E  P E R S P E C T I V E S  
 
The AMR crisis has prompted a tremendous and renewed interest in the discovery of 
microbially-derived novel bioactive compounds. Exploring the world’s oceans has 
revealed this vast ecosystem as a trove of unique bacterial taxa with promising 
biosynthetic potential. While they collectively represent a remarkable resource to 
unearth new natural products, the actual discovery of novel molecules from these 
microorganisms is limited because most of the BGCs they encode are not expressed 
under typical laboratory settings. This is certainly true for the marine actinobacterium 
Salinispora, as an astonishing 80% of its BGCs are still orphan.  
In Chapter two, we addressed this issue by examining how co-cultivation of S. tropica 
with marine phototrophs could be used to stimulate its biosynthetic activity and impact 
its metabolome for novel natural product discovery. In Chapter three, we used high-
throughput proteomics to provide a better understanding of these co-cultures by 
identifying candidate BGCs that were up-regulated in response to phytoplankton. Finally, 
in Chapter four we implemented for the first time the CRISPR/Cas9 system in S. tropica, 
as a promising tool to link specific BGCs to detected molecules and/or observed 
bioactivity. The main findings and hypotheses resulting from these chapters are depicted 
in Figure 32. 
 
1. EXPLOITING PHYTOPLANKTON TO AWAKEN SILENT BGCS 
Historically, natural product research has heavily relied on growing actinomycetes in 
monoculture and in nutrient-rich broth. Although fruitful for decades, this approach 
rapidly showed its limitation as the post-genomic era revealed that the pool of secondary 
metabolites isolated from actinomycetes represented only a small fraction of the actual 
biosynthetic capability encoded in their genomes. This derives, in part, from the fact that 
cultivating microbes in typical laboratory conditions is fundamentally a poor proxy for 
their natural environments, lacking the myriad of molecular cues required for the 
induction of their secondary pathways. As most of those signals come from the 
interactions with other microorganisms, simulating small-scale communities by co-
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cultivation of secondary metabolite producers has proven an efficient method to awaken 
silent BGCs (Abdalla et al., 2017; Bertrand et al., 2014; Yu et al., 2019).  
For instance, co-cultivation of the marine-derived fungal Aspergillus fumigatus with 
Streptomyces leeuwenhoekii lead to the characterization of the lasso peptide 
chaxapeptin from the latter species (Wakefield et al., 2017). The BGC encoding the 
compound had been previously identified by genomic analysis two years prior but its 
product was not detected when S. leeuwenhoekii was grown in monoculture (Gomez-
Escribano et al., 2015). In another study, production of the antibiotics istamycin from the 
marine bacterium Streptomyces tenjimariensis was shown to increase upon exposure to 
twelve different bacterial species, which were sensitive to the antimicrobial compound 
(Slattery et al., 2001). This observation interestingly suggested the ecological role of 
istamycin as a mean to subdue competitive species. 
 
Figure 32 | Interaction of Salinispora tropica with phytoplankton. Marine phototrophs 
release photosynthate that triggers the biosynthesis of novel cryptic metabolites in S. tropica. 
S. tropica produces an unknown antimicrobial molecule that kills phytoplankton. The proposed 
mechanism of the antimicrobial metabolite as well as the activity of the nrps1 product are 
depicted (green and purple boxes, respectively). We hypothesize that the BGC nrps1 may 
produce a ClpP-proteasome inhibitor, to which S. tropica would be resistant because of an 
immunity protein encoded within the BGC, similarly to what is known for sal/salinosporamide. 
The nrps1-encoded proteasome inhibitor could kill the phototrophs by preventing protein 
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In Salinispora, co-culture has been employed but failed so far to result in the discovery 
of novel natural products from the genus. Co-inoculation of S. arenicola with the marine 
fungus Emericella sp. induced production of the emericellamide compound in the latter 
species only (Oh et al., 2007). More recently, Patin and colleagues showed that S. 
arenicola and S. tropica strains exhibited antimicrobial activities against various marine 
heterotrophs (Patin et al., 2018, 2016, 2017). Although some of these interactions were 
found to be caused by already known bioactive compounds (e.g. siderophores), several 
of those were mediated by an uncharacterized mechanism and overall no new natural 
product was identified (Patin et al., 2016). In a following manuscript, the interactions 
between S. tropica CNY-681 and several heterotrophs were further explored by MS/MS 
networking analysis (Patin et al., 2018). The networks generated revealed unknown 
molecular families unique to the co-cultures but they were either (i) not proven to be 
produced by S. tropica rather than the co-inoculated heterotroph or (ii) related to the 
already characterized siderophore desferrioxamine E (Patin et al., 2018). These studies, 
however, provided a valuable insight on the ecological significance of the genus 
Salinispora and of its role within benthic microbial communities (Patin et al., 2017).  
The work presented in Chapter two expands our understanding of the impact that the 
Salinispora genus has on the complex microbial communities inhabiting the seas. Using 
metabolomics, we characterized the production of cryptic metabolites in the type strain 
Salinispora tropica CNB-440T in response to the presence of a range of prokaryotic and 
eukaryotic phytoplankton species. Molecules with identical m/z were never reported in 
the literature and they were also distinct from the molecular families described by Patin 
et al. when S. tropica was grown with marine heterotrophs (Patin et al., 2018). This 
finding confirms the overlooked potential of co-culturing Salinispora specifically with 
phytoplankton to elicit the production of novel secondary metabolites. We also showed 
that S. tropica intriguingly inhibits the growth of these marine phototrophs via a 
mechanism we could not link to the cryptic compounds (Fig. 32). This observation is of 
significance as a growing body of evidence suggests that members of the genus 
Salinispora may be more exposed to phytoplankton than what was previously thought, 
whether because they sediment out of the water column, grow in sunlit coastal 
sediments or belong to the same coral-associated microbiota (Guidi et al., 2016; 
Ocampo-Alvarez et al., 2020; Patin et al., 2017).  
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Understanding the ecological context of the producer organisms is becoming crucial for 
natural product discovery, as improving our knowledge of the interactions occurring in 
their environments allows to uncover the specific cues that trigger the expression of 
silent BGCs (Adnani et al., 2017; Behie et al., 2017; van der Meij et al., 2017). For instance, 
work by Onaka et al. demonstrated that the mycolic acid contained in the outer cell layer 
of different bacteria induced production of a red pigment in various Streptomyces 
species (Onaka et al., 2011). Such examples were also reported from the seas, as a study 
led by Seyedsayamdost et al. showed that the marine proteobacterium Phaeobacter 
gallaeciensis inhibits the growth of the microalgae E. huxleyi in co-culture by producing 
the algaecidal molecule roseobacticide (Seyedsayamdost et al., 2011). Interestingly, they 
were able to demonstrate that the production of this bioactive secondary metabolite 
was dependent on p-coumaric acid, a compound characteristic of aging algae that 
accumulates when they reach stationary phase. P-coumaric acid acted as a chemical cues 
that specifically triggered the otherwise silent biosynthetic pathway of roseobacticide, 
therefore controlling the dynamics of P. gallaeciensis-E. huxleyi interactions 
(Seyedsayamdost et al., 2011).  
In our study, the requirement of photosynthate for the detection of the cryptic molecules 
comes with a set of challenges that future work should address. First, the vast diversity 
of phototrophic microbes found in the world’s oceans should be explored and tested in 
co-culture with marine actinobacteria to investigate the extent of their potential to 
induce silent BGCs. Second, most of those phytoplankton can be arduous to grow in the 
laboratory and as such, efforts should be directed toward the improvement of cultivation 
media and techniques for marine phototrophs. For example, supporting the growth of 
the cyanobacteria Synechococcus in large volumes turned out to be one of the major 
limitations in our attempt to elucidate the structure of our cryptic compounds by NMR. 
Concurrently, future research should focus on identifying the exact chemical signals of 
photosynthate that prompt the production of the cryptic compounds in our co-culture 
system. If the specific compounds were to be identified, it could facilitate the isolation 
and characterization of novel natural products, as exemplified by the discovery of the 
algaecidal roseobacticide molecule linked to p-coumaric acid (Seyedsayamdost et al., 
2011). One could, for instance, extract or chemically synthesize versions of the inducing 
compounds to elicit the expression of silent BGCs in Salinispora, or other marine 
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actinobacteria, grown in large scales without the need of phototrophs. Finally, our data 
warrants a broader investigation of the true ecological niches of members of the genus 
Salinispora and of their study in situ as a mean to harvest new bioactive secondary 
metabolites.  
 
2. EXPLOITING -OMICS TO GAIN INSIGHT ON BIOSYNTHETIC ACTIVITY 
The advent of next-generation sequencing technologies, coupled with bioinformatics 
pipelines such as antiSMASH, have propelled the use of genome mining of BGCs for 
natural product discovery. The amount of data that has resulted from these extensive 
mining efforts is colossal, as they have, to date, led to the identification of more than 
300,000 putative BGCs, of which less than 0.5% are experimentally verified (Blin et al., 
2019; Medema et al., 2011; Palaniappan et al., 2020). The overwhelming wealth of 
available genomic data at our disposal requires to establish methods to prioritize the 
study of orphan BGCs. One way consists of identifying the BGCs that are effectively silent 
(due to a poor or conditional level of expression or inactivation of their biosynthetic 
genes) from those simply producing compounds that are difficult to detect and isolate 
(due to compound instability, limited sensitivity of detection methods or absence of 
bioactivity to screen for). As genomic-based approaches alone do not allow such 
discernment, other -omics technologies are instrumental for the discovery of novel 
natural products (Palazzotto & Weber, 2018).  
In Salinispora, bioinformatic analysis of the draft genomes of 119 strains predicted 176 
distinct BGCs, of which 80% are still orphan (Letzel et al., 2017). This is exemplified in the 
type strain S. tropica CNB-440T, which encodes in its genome at least twenty putative 
BGCs and only nine have been assigned to a natural product so far. Based on the 
sequences of these orphan BGCs alone, it is difficult to prioritize and identify promising 
clusters for natural product discovery. A recent work led by Amos and colleagues used 
comparative transcriptomics of different Salinispora species to isolate the molecule 
salinipostin, as well as identify seven transcriptionally silent BGCs (Amos et al., 2017). 
This study was the first to investigate the transcriptome of Salinispora to obtain 
information on the genus clusters beyond genomic approaches. It was done, however, 
solely on strains of Salinispora growing axenically in rich broth, therefore providing 
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limited information on the actual biosynthetic activity profile that the actinobacterium 
may have in its natural environment. Additionally, transcriptomics typically depicts an 
imprecise vision of an organism metabolism, because the level of transcription of a given 
gene is an approximate estimate of its protein expression level (i.e. mRNA degradation, 
poor translation efficiency, post-translational modifications etc.). Meanwhile, 
proteomics approaches have proven successful to discover new secondary metabolites 
and link them to their corresponding BGCs (Du & van Wezel, 2018). For instance, a 
proteomining concept based on quantitative proteomics used the correlations between 
abundance of natural products or antimicrobial activity and concurrent variations in the 
bacterium proteome to identify the matching gene cluster (Gubbens et al., 2014). 
In Chapter three, we employed for the first time a proteomic-based approach in the 
genus Salinispora to identify candidate biosynthetic pathways that could be responsible 
for the production of the cryptic compounds and/or the antimicrobial activity described 
in our co-culture study. By using state-of-the-art high-throughput proteomics, we 
reported the activity of orphan BGCs that were previously thought to be silent in S. 
tropica. In particular, we provided evidence suggesting that the nrps1 BGC is upregulated 
when this actinobacterium is exposed to phytoplankton and discussed a potential 
mechanism for the antimicrobial effect of S. tropica upon marine phototrophs (Fig. 29). 
Our proteomic analysis generated promising hypotheses that further experimental work 
will confirm, such as inactivation of the candidate BGCs. Also, as our data suggested 
several orphans BGCs to be expressed (e.g. pks3, nrps1 and nrps2) that may be producing 
secondary metabolites undetected in our experimental setup, different analytical 
chemistry methods must be explored in order to characterize the products of these 
potentially active BGCs. Additional research efforts should extend our study to other 
species of the genus Salinispora, as well as testing various growth conditions and media. 
Looking into the proteomes of the phytoplankton we co-inoculated with S. tropica could 
also be of interest as it could reveal important clues to understand the nature of their 
interactions. Overall, employing proteomics in a more systematic way when examining 
marine actinobacteria should dramatically improve our understanding of their 




3. BETTER TOOLS TO ENGINEER MARINE ACTINOBACTERIA 
As mentioned above, genome- or proteome-based approaches alone do not always 
allow the isolation of new compounds. Whether it is because identified orphans BGCs 
are silent or encoding undetectable molecules, altering the genome of producing strains 
can be crucial for natural products discovery and is widely used in Streptomyces species. 
For instance, inactivating a transcriptional repressor encoded within a silent gene cluster 
using CRISPR/Cas9 resulted in the production of scleric acid in Streptomyces albus 
(Alberti et al., 2019). In Salinispora, however, very few examples of genetic engineering 
have been reported in the literature, but they are all based upon integrative vectors and 
PCR-targeted mutagenesis. In order to investigate the salt requirement of the genus, the 
integrative plasmid pSET152 was used to introduce the mscL gene at the pseudo-attB 
phage attachment sites present in the genome of S. tropica (Bucarey et al., 2012). The λ-
Red-mediated recombination method was also employed to chromosomally replace 
the salL chlorinase gene of the sal BGC with a fluorinase gene flA, leading to the 
production of fluorosalinosporamide (Eustáquio et al., 2011). In all cases, generation of 
the recombinant strains of Salinispora suffered from several disadvantages. It either 
relied on a single cross-over event that lacks stability, integrated selectable markers that 
limits the number of genomic modifications possible or required relatively time-
consuming additional steps to obtain marker-free mutants (Datsenko & Wanner, 2000; 
Gust et al., 2003; Kieser et al., 2000). Conversely, the CRISPR/Cas9 technology has been 
applied successfully in soil actinobacteria for rapid generation of marker-less and stable 
double cross-over mutants but has yet to be used in Salinispora (Alberti et al., 2019; Jinek 
et al., 2012). 
In Chapter four, we implemented for the first time the marker-less and multiplex genome 
editing method CRISPR/Cas9 in S. tropica, deleting successfully the entire nrps2 BGC, as 
well as the PPTase 2496. The analysis by proteomics of the post-translational 
modifications of the ACPs/PCPs in the S. tropica PPTase-deficient strain suggested the 
functional redundancy of the PPTase 0777, providing a clear indication of the next steps 
to be carried out to test our strategy. Future work should, indeed, delete the PPTase 
0777 in order to use the resulting recombinant cell as a starter strain for further genome 
editing of the remaining PPTases. Ultimately, we believe that disruption of these broad-
specificity enzymes represents a promising way to inactivate multiple BGCs via single 
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gene deletion. Focussing on groups of BGCs, rather than working at the individual BGC 
scale, when using genetic engineering could greatly facilitate the prioritization and 
screening of orphan BGCs.  
The many challenges we have faced while attempting the different genetic modifications 
of S. tropica highlighted the urgency with which we need to develop better genome 
engineering tools for marine actinobacteria. Most of these microbes are currently 
difficult to cultivate in the laboratory or genetically intractable, which hampers our ability 
to exploit efficiently their biosynthetic potential for natural product discovery. For 
instance, key factors for the efficient transfer of DNA in marine actinobacteria should be 
identified for the establishment of robust and reproducible methods. More globally, sets 
of molecular biology tools must be created for these marine bacteria (e.g. inducible 
promoters, regulators etc.). For instance, no replicative plasmids have been formally 
reported to function in the genus Salinispora, although we believe the pCRISPomyces-2 
vector was able to propagate in our cells based on the isolation of apramycin-resistant 
exconjugants. Collectively, the development of these currently lacking means to 
manipulate and interrogate the biosynthetic ability of these rare actinomycetes that are 
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Appendix 2 | MS/MS fragmentation spectra of the cryptic molecules. High-resolution 



















Appendix 3 | Graph shows overlaid base peak chromatograms issued from the LC-MS 
analysis of the HPLC-collected fractions 1 (red), 2 (orange), 3 (green) and 4 (blue), 




















Appendix 4 | 1H-NMR spectrum (700 MHz, (d6DMSO) of the HPLC fraction containing 
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Appendix 5 | List of primers used to retarget the pCRISPomyces-2 plasmid. 
 
Name Sequence 5’—3’ Description
AC_025 ACGCcctccggcaggcagattgcc
Protospacer for PPtase 0777 (STROP_RS03935)
AC_026 AAACggcaatctgcctgccggagg
AC_029 ACGCctccggccactcaggcaggt
Protospacer for PPTase 685 (STROP_RS03465)
AC_030 AAACacctgcctgagtggccggag
AC_037 ACGCcttgaggagtgcttccttcc
Protospacer for PPTase 2822 (STROP_RS14165)
AC_038 AAACggaaggaagcactcctcaag
AC_041 ACGCccaaccgatccacacataca
Protospacer for PPTase 2496 (STROP_RS12565)
AC_042 AAACtgtatgtgtggatcggttgg
AC_047 tcggttgccgccgggcgttttttatAACCTCATCGAGTACCACC Amplify homology arms A for PPTase777 - Fwd
AC_048 gccctccgatgacagggtggCAGTCCAGAGTCTGCGTG Amplify homology arms A for PPTase777 - Rvs
AC_049 gtcacgcagactctggactgCCACCCTGTCATCGGAG Amplify homology arms B for PPTase777 - Fwd
AC_050 gcggcctttttacggttcctggcctCAGGGATCGTCGGTCTG Amplify homology arms B for PPTase777- Rvs
AC_051 tcggttgccgccgggcgttttttatGCACATCCTTCACATCG Amplify homology arms A for PPTase685 - Fwd
AC_052 gggggcagccatggtgacagATGACCGTTCCGGATTC Amplify homology arms A for PPTase685 - Rvs
AC_053 cgggaatccggaacggtcatCTGTCACCATGGCTGCC Amplify homology arms B for PPTase685 - Fwd
AC_054 gcggcctttttacggttcctggcctGAACAGGTTGACGGCCAG Amplify homology arms B for PPTase685 - Rvs
AC_059 tcggttgccgccgggcgttttttatTGTATCCCACCCCGATCTG Amplify homology arms A for PPTase2822 - Fwd 
AC_060 gacggaaaggtggcaccaccACCGCTCCTCCATAGCCA Amplify homology arms A for PPTase2822 - Rvs
AC_061 ggtggctatggaggagcggtGGTGGTGCCACCTTTCC Amplify homology arms B for PPTase2822 - Fwd
AC_062 gcggcctttttacggttcctggcctCCAGGTATCCAGGGTAGGTG Amplify homology arms B for PPTase2822 - Rvs
AC_063 tcggttgccgccgggcgttttttatATCCTGCTTCCGTCCATG Amplify homology arms A for PPTase2496 - Fwd
AC_064 gttaacctctctccgtgaacGATGTCGCCGATGTGTG Amplify homology arms A for PPTase2496 - Rvs
AC_065 acccacacatcggcgacatcGTTCACGGAGAGAGGTTAACC Amplify homology arms B for PPTase2496 - Fwd
AC_066 gcggcctttttacggttcctggcctGTTGGTTCCCGAGACACAC Amplify homology arms B for PPTase2496 - Rvs
AC_069 tcggttgccgccgggcgttttttatGGCTTCTTCTCCTCCTTCTCC Amplify homology arms A for NRPS2 - Fwd
AC_070 cggctgagcacctggtccacCTTGCTGAGATGTCGGTAAGG Amplify homology arms A for NRPS2 - Rvs
AC_071 cttaccgacatctcagcaagGTGGACCAGGTGCTCAGC Amplify homology arms B for NRPS2 - Fwd
AC_072 gcggcctttttacggttcctggcctAGAACCTCGGTAGCGTACTCC Amplify homology arms B for NRPS2 - Rvs
AC_089 tcggttgccgccgggcgttttttatGTCACGGTGGCTCAGACTAC Amplify homology arms A for NRPS1 - Fwd
AC_090 tcgggtgggtgggttggttcCTGCTGTCGTTTCTCACCTG Amplify homology arms A for NRPS1 - Rvs
AC_091 caggtgagaaacgacagcagGAACCAACCCACCCACCC Amplify homology arms B for NRPS1 - Fwd























gBlock for nrps1 guide RNAs such as BbsI-spacer1-
gRNAtail-T7term-gapdhp(EL)-spacer2-BbsI
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Appendix 6 | List of primers used for PCR-verification of the S. tropica exconjugants. 
 
  
Name Sequence 5’—3’ Description Expected size
AC_099 CTCGATCGCCACGTTATCTG Check knock-out of PPTase 685 outside homology arms - Fwd
2,622 bp if WT
1,940 bp if KO
AC_100 CGTGGTGCTGTCGGTCTG Check knock-out of PPTase 685 outside homology arms - Rvs
AC_101 CTGGTGGTCTTCTGGGAGG Check knock-out of PPTase 777 outside homology arms - Fwd
2,784 bp if WT
2,050 bp if KO
AC_102 CTGCCAGAGGTGAACAGCA Check knock-out of PPTase 777 outside homology arms - Rvs
AC_084c GGGTCTTCGTCGATGTCACT Check knock-out of PPTase2496 outside homology arms - Fwd
2,642 bp if WT
2,142 bp if KO
AC_085c GAAGAGGGCGTACTGGTCG Check knock-out of PPTase2496 outside homology arms - Rvs
AC_095 gacgggcatgatgggatcta Check knock-out nrps1 - amplify within the BGC nrps1 - Fwd
892 bp if WT
No amplicon if KO
AC_096 caaagatctggtcgccgaag Check knock-out nrps1 - amplify within the BGC nrps1 - Rvs
AC_097 AAGATCACAGCCCAGGGAAA Check knock-out of nrps1 outside homology arms - Fwd
40,700 bp if WT
571 bp if KO
AC_098 ACCTGGAGCATGATCTACCG Check knock-out of nrps1 outside homology arms - Rvs
AC_086b GCCACCATAGAACGTTGC Check knock-out of NRPS2 outside homology arms - Fwd
37,143 bp if WT
2,448 bp if KO
AC_087b CCACCGCCAGATCTAAAGG Check knock-out of NRPS2 outside homology arms - Rvs
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Appendix 7 | MS analysis detecting the PPTase-modified peptide of protein A4X7U8, at 
different charge states. Chromatograms show isolated ion spectra with the mass 
differences between related peaks that are indicative of the ion charge represented by 
an arrow. 
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